2o9i:A   (GLU321) to   (LEU428)  CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND T0901317  |   NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, PXR, T0901317, TRANSCRIPTION 
2o9i:B  (PRO1322) to  (PHE1429)  CRYSTAL STRUCTURE OF THE HUMAN PREGNANE X RECEPTOR LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND T0901317  |   NUCLEAR RECEPTOR, PREGNANE X RECEPTOR, PXR, T0901317, TRANSCRIPTION 
1n83:A   (GLU397) to   (PHE511)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ORPHAN NUCLEAR HORMONE RECEPTOR ROR(ALPHA)-LBD AND CHOLESTEROL  |   THREE-LAYERED ALPHA HELICAL SANDWICH, RECEPTOR, TRANSCRIPTION REGULATION, NUCLEAR PROTEIN, DNA BINDING, LIPID BINDING PROTEIN 
2ao6:A   (MET780) to   (SER888)  CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE AND R1881  |   CRYSTAL STRUCTURE; HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN; TRANSCRIPTIONAL INTERMEDIARY FACTOR 2 740-753; R188 
2ath:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IM COMPLEX WITH AN AGONIST  |   PPAR, TRANSCRIPTION 
2om9:A   (ARG357) to   (TYR473)  AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA  |   PPAR GAMMA, AJULEMIC ACID, CANNABINOID, PARTIAL AGONIST, TRANSCRIPTION 
2om9:B   (MET364) to   (TYR473)  AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA  |   PPAR GAMMA, AJULEMIC ACID, CANNABINOID, PARTIAL AGONIST, TRANSCRIPTION 
2om9:C   (ARG357) to   (TYR473)  AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA  |   PPAR GAMMA, AJULEMIC ACID, CANNABINOID, PARTIAL AGONIST, TRANSCRIPTION 
2om9:D   (MET364) to   (TYR473)  AJULEMIC ACID, A SYNTHETIC CANNABINOID BOUND TO PPAR GAMMA  |   PPAR GAMMA, AJULEMIC ACID, CANNABINOID, PARTIAL AGONIST, TRANSCRIPTION 
2awh:A   (LYS358) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION 
2awh:B   (LYS358) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION 
2b1v:A   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2b1v:B   (MET421) to   (ASP545)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2b1z:A   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17METHYL-17ALPHA-DIHYDROEQUILENIN AND A GLUCOC INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2b1z:B   (MET421) to   (LEU544)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17METHYL-17ALPHA-DIHYDROEQUILENIN AND A GLUCOC INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2b23:A   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2b23:B   (GLU419) to   (ALA546)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
1nrl:A   (GLU321) to   (LEU428)  CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813  |   NUCLEAR RECEPTOR, COACTIVATOR, PXR, XENOBIOTIC, SRC-1, LIGAND BINDING DOMAIN, TRANSCRIPTION 
2b50:A   (LYS358) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION 
2b50:B   (LYS358) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, GENE REGULATION 
2ouz:A   (MET421) to   (MET543)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA-LASOFOXIFENE COMPLEX  |   NUCLEAR RECEPTOR, SERM, ESTROGEN, HORMONE-GROWTH FACTOR COMPLEX 
1nuo:A   (VAL348) to   (PHE459)  TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING  |   ALPHA HELIX, NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
2oz7:A   (TYR781) to   (GLN902)  CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR T877A MUTANT LIGAND- BINDING DOMAIN WITH CYPROTERONE ACETATE  |   ANDROGEN RECEPTOR, ANTI-ANDROGEN, PROSTATE CANCER, HORMONE RECEPTOR 
2p15:A   (MET421) to   (LEU544)  CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL  |   NULEAR RECEPTOR, LIGAND BINDING DOMAIN, HELIX 12, HORMONE RECEPTOR 
2p15:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER ALPHA LIGAND BINDING DOMAIN WITH THE AGONIST ORTHO-TRIFLUOROMETHYLPHENYLVINYL ESTRADIOL  |   NULEAR RECEPTOR, LIGAND BINDING DOMAIN, HELIX 12, HORMONE RECEPTOR 
1nyx:B   (ARG357) to   (LYS474)  LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST  |   PPAR, NUCLEAR RECEPTOR, TRANSCRIPTION, GENE REGULATION, AGONIST COMPLEX 
2baw:A   (LYS358) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION 
2baw:B   (PHE360) to   (TYR473)  HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION 
3erd:A   (MET421) to   (LEU549)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, AGONIST, COACTIVATOR 
3erd:B   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, AGONIST, COACTIVATOR 
2p4y:A   (PHE360) to   (TYR473)  CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA-LIGAND BINDING DOMAIN COMPLEXED WITH AN INDOLE-BASED MODULATOR  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, LBD, ALPHA HELIX SANDWICH, PPAR-HOMODIMER, SPPARGM, PARTIAL AGONIST, TRANSCRIPTION 
2p54:A   (LYS349) to   (TYR464)  A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735  |   PPAR ALPHA GW735 SRC1 AGONIST HDLC, TRANSCRIPTION 
3et0:A   (ARG357) to   (TYR473)  STRUCTURE OF PPARGAMMA WITH 3-(5-METHOXY-1H-INDOL-3-YL)- PROPIONIC ACID  |   PPAR, PPARG, PPARGAMMA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3et1:A   (ARG348) to   (ARG465)  STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID  |   PPAR, PPARA, PPARALPHA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, ALTERNATIVE SPLICING, CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSFERASE COMPLEX 
3et1:B   (GLU356) to   (TYR464)  STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID  |   PPAR, PPARA, PPARALPHA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, ALTERNATIVE SPLICING, CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSFERASE COMPLEX 
3et2:A   (ILE328) to   (LYS438)  STRUCTURE OF PPARDELTA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID  |   PPAR, PPARD, PPARDELTA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, K.ZHANG, WED OCT 1 17:27:09 2008 ON NOD 
3et2:B   (ILE328) to   (LYS438)  STRUCTURE OF PPARDELTA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID  |   PPAR, PPARD, PPARDELTA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, K.ZHANG, WED OCT 1 17:27:09 2008 ON NOD 
3et3:A   (ARG357) to   (TYR473)  STRUCTURE OF PPARGAMMA WITH 3-[5-METHOXY-1-(4-METHOXY- BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID  |   PPAR, PPARG, PPARGAMMA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION 
4x1g:A   (GLU321) to   (LEU428)  CRYSTAL STRUCTURE OF THE HPXR-LBD IN COMPLEX WITH THE SYNTHETIC ESTROGEN 17ALPHA-ETHINYLESTRADIOL AND THE PESTICIDE TRANS-NONACHLOR  |   HORMONE RECEPTOR, ESTROGEN, PESTICIDE, GENE REGULATION 
3f7d:A   (SER343) to   (ALA459)  SF-1 LBD BOUND BY PHOSPHATIDYLCHOLINE  |   NUCLEAR RECEPTOR, COACTIVATOR PEPTIDE, LIGAND, PHOSPHOLIPID, PHOSPHATIDYLCHOLINE, TRANSCRIPTIONAL REGULATION, DNA-BINDING, METAL- BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR, RNA-BINDING 
3s9s:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF PPARGAMMA COMPLEXED WITH A BENZIMIDAZOLE PARTIAL AGONIST  |   PPAR, NUCLEAR RECEPTOR, TRANSCRIPTION 
3fal:D   (GLN330) to   (TRP441)  HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186  |   NUCLEAR HORMONE RECEPTOR NONSTEROIDAL LXR AGONIST CHOLOESTOROL METABOLISM, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, SIGNALING PROTEIN 
4xao:A   (PRO322) to   (PHE429)  CRYSTAL STRUCTURE OF THE HPXR-LBD OBTAINED IN PRESENCE OF THE PESTICIDE TRANS-NONACHLOR  |   HORMONE RECEPTOR, PESTICIDE, GENE REGULATION 
3fc6:D   (GLN330) to   (TRP441)  HRXRALPHA & MLXRALPHA WITH AN INDOLE PHARMACOPHORE, SB786875  |   LIVER X RECEPTOR, NUCLEAR HORMONE RECEPTORS, AGONISTS, EPOXYCHOLESTEROL, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER 
2piq:A   (MET780) to   (SER888)  ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE  |   ANDROGEN RECEPTOR, INHIBITORS COACTIVATOR BINDING AF-2, HORMONE RECEPTOR 
2piw:A   (TYR781) to   (SER888)  ANDROGEN RECEPTOR WITH SMALL MOLECULE  |   ANDROGEN RECEPTOR INHIBITORS COACTIVATOR BINDING, HORMONE RECEPTOR 
3fei:A   (ARG348) to   (TYR464)  DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL PPARA/G AGONISTS  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2pob:A   (GLU365) to   (TYR473)  PPARGAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A FARGLITAZAR ANALOGUE GW4709  |   PPARG, NUCLEAR RECEPTOR,PPAR, GENE REGULATION 
2pog:A   (VAL422) to   (MET543)  BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR B AGONISTS (SERBAS). PART 2: STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON THE BENZOPYRAN SCAFFOLD.  |   NUCLEAR RECEPTOR, LIGAND-BINDING, LIPID BINDING PROTEIN 
3sp9:A   (LYS322) to   (TYR437)  STRUCTURAL BASIS FOR ILOPROST AS A DUAL PPARALPHA/DELTA AGONIST  |   NUCLEAR RECEPTOR LBD, NUCLEAR RECEPTOR FOLD, LIGAND BINDING, GENE TRANSCRIPTION, DRUG BINDING, TRANSCRIPTION 
3sp9:B   (LYS322) to   (THR427)  STRUCTURAL BASIS FOR ILOPROST AS A DUAL PPARALPHA/DELTA AGONIST  |   NUCLEAR RECEPTOR LBD, NUCLEAR RECEPTOR FOLD, LIGAND BINDING, GENE TRANSCRIPTION, DRUG BINDING, TRANSCRIPTION 
2q3y:A   (TYR109) to   (GLY237)  ANCESTRAL CORTICIOD RECEPTOR IN COMPLEX WITH DOC  |   NUCLEAR RECEPTOR, MINERALOCOTICIOD, LIGAND BINDING DOMAIN, DOC, CORTISOL, EVOLUTION, TRANSCRIPTION 
3fur:A   (MET364) to   (TYR477)  CRYSTAL STRUCTURE OF PPARG IN COMPLEX WITH INT131  |   NUCLEAR RECEPTOR, PPARGAMMA, X-RAY, CRYSTAL STRUCTURE, PARTIAL AGONIST, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, INT131, TRANSCRIPTION/TRANSCRIPTION REGULATOR COMPLEX 
2q59:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LBD BOUND TO FULL AGONIST MRL20  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q5g:A   (LYS358) to   (LYS474)  LIGAND BINDING DOMAIN OF PPAR DELTA RECEPTOR IN COMPLEX WITH A PARTIAL AGONIST  |   PPAR DELTA, TRANSCRIPTION 
2q5s:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST NTZDPA  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q61:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN BOUND TO PARTIAL AGONIST SR145  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q61:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN BOUND TO PARTIAL AGONIST SR145  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q6s:A   (ARG357) to   (ILE472)  2.4 ANGSTROM CRYSTAL STRUCTURE OF PPAR GAMMA COMPLEXED TO BVT.13 WITHOUT CO-ACTIVATOR PEPTIDES  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q7i:A   (MET780) to   (GLN902)  THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND AN AR 20-30 PEPTIDE  |   ANDROGEN RECEPTOR STEROID NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TESTOSETERONE, N-TERMINAL AR PEPTIDE, TIF2 BOXIII COACTIVATOR PEPTIDE, HORMONE 
2q7j:A   (MET780) to   (SER888)  THE WILD TYPE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH TESTOSTERONE AND A TIF2 BOX 3 COACTIVATOR PEPTIDE 740-753  |   ANDROGEN RECEPTOR STEROID NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TESTOSETERONE, TIF2 BOXIII COACTIVATOR PEPTIDE, HORMONE 
2q8s:A   (ARG357) to   (LYS474)  X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST  |   LIGAND-BOUND COMPLEX, HORMONE RECEPTOR 
2qa6:A   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA MUTANT 537S COMPLEXED WITH 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
2qa8:A   (GLY442) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
3sz1:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH LUTEOLIN AND MYRISTIC ACID  |   PPAR GAMMA, NUCLEAR RECEPTOR, LUTEOLIN, TRANSCRIPTION 
3t03:A   (LYS386) to   (TYR501)  CRYSTAL STRUCTURE OF PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A NOVEL PARTIAL AGONIST GQ-16  |   PROTEIN-DRUG COMPLEX, THIAZOLIDINEDIONES, LIGAND BINDING PROTEIN, TRANSCRIPTION FACTOR, NUCLEUS RECEPTOR, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
3t03:B   (ARG385) to   (TYR501)  CRYSTAL STRUCTURE OF PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A NOVEL PARTIAL AGONIST GQ-16  |   PROTEIN-DRUG COMPLEX, THIAZOLIDINEDIONES, LIGAND BINDING PROTEIN, TRANSCRIPTION FACTOR, NUCLEUS RECEPTOR, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
1p8d:B   (GLN346) to   (TRP457)  X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH 24(S),25- EPOXYCHOLESTEROL  |   LXR, EPOXYCHOLESTEROL, NUCLEAR RECEPTOR, STEROID RECEPTOR, LIVER X RECEPTOR, TRANSCRIPTION, MEMBRANE PROTEIN-PROTEIN BINDING COMPLEX 
1db1:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D  |   COMPLEX, GENE REGULATION 
2qgt:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO AN ETHER ESTRADIOL COMPOUND  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
2qh6:B   (MET421) to   (HIS547)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DIARYLETHYLENE COMPOUND  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
3g8i:A   (LYS349) to   (TYR464)  ALEGLITAZAR, A NEW, POTENT, AND BALANCED PPAR ALPHA/GAMMA AGONIST FOR THE TREATMENT OF TYPE II DIABETES  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, ALTERNATIVE SPLICING, CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, PROTO- ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSFERASE COMPLEX 
3g9e:A   (LYS358) to   (TYR473)  ALEGLITAAR. A NEW. POTENT, AND BALANCED DUAL PPARA/G AGONIST FOR THE TREATMENT OF TYPE II DIABETES  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSFERASE COMPLEX 
3gbk:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A POTENT AND SELECTIVE AGONIST  |   PPAR AGANISTS, X-RAY CO-CRYSTAL ANALYSIS, STRUCTURE-BASED DRUG DESIGN, SELECTIVE, TYPE II DIABETES, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, LIGAND BINDING PROTEIN 
3gbk:B   (GLU365) to   (TYR473)  CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A POTENT AND SELECTIVE AGONIST  |   PPAR AGANISTS, X-RAY CO-CRYSTAL ANALYSIS, STRUCTURE-BASED DRUG DESIGN, SELECTIVE, TYPE II DIABETES, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, LIGAND BINDING PROTEIN 
4xum:A   (GLU365) to   (TYR473)  PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH INDOMETHACIN  |   PPARGAMMA, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, NSAIDS, INDOMETHACIN, TRANSLATION 
4xum:B   (LYS358) to   (TYR473)  PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH INDOMETHACIN  |   PPARGAMMA, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, NSAIDS, INDOMETHACIN, TRANSLATION 
4is8:A   (GLU421) to   (ALA538)  DIVERGENT SEQUENCE TUNES LIGAND SENSITIVITY IN PHOSPHOLIPID-REGULATED HORMONE RECEPTORS  |   LIGAND BINDING DOMAIN, TRANSCRIPTION 
4is8:B   (VAL422) to   (ALA538)  DIVERGENT SEQUENCE TUNES LIGAND SENSITIVITY IN PHOSPHOLIPID-REGULATED HORMONE RECEPTORS  |   LIGAND BINDING DOMAIN, TRANSCRIPTION 
2qpy:A   (MET780) to   (SER888)  AR LBD WITH SMALL MOLECULE  |   ANDROGEN RECEPTOR DHT COACTIVATOR, DNA-BINDING, LIPID- BINDING, METAL-BINDING, NUCLEUS, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, DNA BINDING PROTEIN 
4itf:A   (SER306) to   (PHE422)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1ALPHA,25-DIHYDROXY-2ALPHA-[2-(1H-TETRAZOLE-1- YL)ETHYL]VITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
4iu7:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 2B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, TRANSCRIPTION 
2qr9:A   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2qr9:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DERIVATIVE COMPOUND  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3t58:B   (PHE406) to   (HIS538)  C76A/C455S MUTANT OF MOUSE QSOX1 CONTAINING AN INTERDOMAIN DISULFIDE  |   OXIDOREDUCTASE 
3t58:C   (GLY405) to   (ILE544)  C76A/C455S MUTANT OF MOUSE QSOX1 CONTAINING AN INTERDOMAIN DISULFIDE  |   OXIDOREDUCTASE 
3t58:D   (GLY405) to   (ILE544)  C76A/C455S MUTANT OF MOUSE QSOX1 CONTAINING AN INTERDOMAIN DISULFIDE  |   OXIDOREDUCTASE 
4iui:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY DERIVATIVE, 4A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, TRANSCRIPTION 
4iui:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY DERIVATIVE, 4A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, TRANSCRIPTION 
3t59:B   (GLY405) to   (ILE544)  C76A/C455S MUTANT OF MOUSE QSOX1 CONTAINING AN INTERDOMAIN DISULFIDE  |   OXIDOREDUCTASE 
4iv2:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 5A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iv4:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 5B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4ivw:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 6B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4ivw:B   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 6B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4ivy:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 7A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4ivy:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 7A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
2qse:A   (MET421) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2qse:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH BURNED MEAT COMPOUND 4-OH-PHIP  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
4iw6:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 7B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iw6:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 7B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iw8:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 9A  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iwc:A   (GLY420) to   (ALA546)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC THIOPHENE-DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iwc:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC THIOPHENE-DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iwf:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC OXIME-DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
1pq6:B   (VAL347) to   (TRP457)  HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX  |   LXRB+KB043546/WAY207380/GW3965, TRANSCRIPTION REGULATION 
1prg:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA  |   THIAZOLIDINEDIONE, LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, APO, TRANSCRIPTION FACTOR, ORPHAN RECEPTOR, GENE REGULATION 
2qw4:B   (TRP151) to   (ASP263)  HUMAN NR4A1 LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER, HORMONE RECEPTOR 
2qw4:D   (ILE152) to   (ASP263)  HUMAN NR4A1 LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER, HORMONE RECEPTOR 
4y29:A   (ARG357) to   (TYR473)  IDENTIFICATION OF A NOVEL PPARG LIGAND THAT REGULATES METABOLISM  |   AF-2 HELIX, LIGAND BINDING POCKET, THREE-LAYER HELICAL SANDWICH, TRANSCRIPTION REGULATOR PPARG, NR1C3, PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR GAMMA, NHR, NUCLEAR RECEPTOR, COACTIVATOR, TRANSCRIPTION FACTOR, DNA BINDING PROTEIN-TRANSCRIPTION COMPLEX 
2qxm:A   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2qxm:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED TO BURNED MEAT COMPOUND PHIP  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2qzo:A   (VAL422) to   (LEU549)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2qzo:B   (VAL422) to   (ASP545)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH WAY-169916  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2r40:D   (MET413) to   (TRP526)  CRYSTAL STRUCTURE OF 20E BOUND ECR/USP  |   NUCLEAR RECEPTOR LIGAND-BINDING DOMAIN, ANTI-PARALLEL ALPHA-HELICAL SANDWICH, ECDYSONE RECEPTOR, ECR, GENE REGULATION 
1pzl:A   (SER253) to   (GLY367)  CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR SRC-1 PEPTIDE  |   TRANSCRIPTION 
4j5w:A   (MET323) to   (PHE429)  CRYSTAL STRUCTURE OF THE APO-PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX  |   PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN 
4j5w:B   (MET323) to   (PHE429)  CRYSTAL STRUCTURE OF THE APO-PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX  |   PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN 
4j5x:C   (GLY343) to   (GLU456)  CRYSTAL STRUCTURE OF THE SR12813-BOUND PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX  |   PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, SR12813, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN 
4j5x:A   (PRO322) to   (PHE429)  CRYSTAL STRUCTURE OF THE SR12813-BOUND PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX  |   PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, SR12813, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN 
4j5x:B   (GLU321) to   (PHE429)  CRYSTAL STRUCTURE OF THE SR12813-BOUND PXR/RXRALPHA LBD HETEROTETRAMER COMPLEX  |   PREGNANE X RECEPTOR, RETINOID X RECEPTOR ALPHA, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, SR12813, ALPHA HELICAL SANDWICH, UNIQUE INTERMOLECULAR BETA-SHEET DIMERIZATION, XENOBIOTIC SENSING, UPREGULATION OF DRUG METABOLISM ENZYMES, RETINOIC ACID-BINDING PROTEIN 
2r6w:A   (MET421) to   (MET543)  ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A SERM  |   ESTROGEN RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, POLYMORPHISM, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2r6w:B   (MET421) to   (ALA546)  ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A SERM  |   ESTROGEN RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, POLYMORPHISM, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
4jaz:B   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA LBD AND TRANS- RESVERATROL  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRNDED BETA-SHEET, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, NUCLEUS, OBESITY, PHOSPHORYLATION, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3tkc:A   (SER306) to   (GLY423)  DESIGN, SYNTHESIS, EVALUATION AND STRUCTURE OF VITAMIN D ANALOGUES WITH FURAN SIDE CHAINS  |   ALPHA-HELICAL SANDWICH, TRANSCRIPTION, CALCITRIOL, PHOSPHORYLATION, NUCLEUS 
3tkm:A   (LYS322) to   (TYR437)  CRYSTAL STRUCTURE PPAR DELTA BINDING GW0742  |   NUCLEAR RECEPTOR, TRANSCRIPTION, TRANSCRIPTION-TRANSCRIPTION ACTIVATOR COMPLEX 
3gyu:A   (LYS634) to   (PHE749)  NUCLEAR RECEPTOR DAF-12 FROM PARASITIC NEMATODE STRONGYLOIDES STERCORALIS IN COMPLEX WITH ITS PHYSIOLOGICAL LIGAND DAFACHRONIC ACID DELTA 7  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, DAFACHRONIC ACID, SRC1, NEMATODE, STRONGYLOIDES STERCORALIS, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3gz9:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA (PPARD) IN COMPLEX WITH A FULL AGONIST  |   PPAR, PPAR DELTA, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, HORMONE, GROWTH FACTOR RECEPTOR, COMPLEX, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, ZINC, ZINC-FINGER 
3h0a:D   (MET364) to   (TYR473)  CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST  |   PPAR, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, HORMONE, GROWTH FACTOR RECEPTOR, COMPLEX, DNA-BINDING, HOST-VIRUS INTERACTION, ISOPEPTIDE BOND, METAL-BINDING, NUCLEUS, RECEPTOR, ZINC-FINGER, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, OBESITY, PHOSPHOPROTEIN, ACYLTRANSFERASE, PROTO-ONCOGENE, TRANSFERASE 
2rew:A   (MET355) to   (TYR464)  CRYSTAL STRUCTURE OF PPARALPHA LIGAND BINDING DOMAIN WITH BMS-631707  |   ALPHA HELICAL, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1ere:C   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1ere:D   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1ere:F   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1qkn:A   (ILE328) to   (ALA452)  RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ANTAGONIST 
4jl4:B   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA LBD AND THE LIGAND LJ570 [(2S)-3-(BIPHENYL-4-YL)-2-(BIPHENYL-4-YLOXY)PROPANOIC ACID]  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRNDED BETA-SHEET, TRANSCRIPTION FACTOR, RXR, TRANSCRIPTION-AGONIST COMPLEX 
1exa:A   (ASP309) to   (GLU417)  ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE ACTIVE R-ENANTIOMER BMS270394.  |   ENANTIOMER DISCRIMINATION, RETINOID LIGAND COMPLEXES, ANTIPARALLEL ALPHA-HELICAL SANDWICH FOLD, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION 
1exx:A   (GLY305) to   (GLU417)  ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395.  |   ENANTIOMER DISCRIMINATION, RETINOID LIGAND COMPLEXES, ANTIPARALLEL ALPHA-HELICAL SANDWICH FOLD, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION 
3tx7:B   (ALA422) to   (ALA538)  CRYSTAL STRUCTURE OF LRH-1/BETA-CATENIN COMPLEX  |   LRH-1, BETA-CATENIN, ARMADILLO REPEAT, NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, PROTEIN BINDING 
3ty0:A   (ARG357) to   (TYR473)  STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH (R)-5-(3- ((3-(6-METHOXYBENZO[D]ISOXAZOL-3-YL)-2-OXO-2,3-DIHYDRO-1H- BENZO[D]IMIDAZOL-1-YL)METHYL)PHENYL)-5-METHYLOXAZOLIDINE-2,4-DIONE  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION REGULATOR 
3ty0:B   (GLU865) to   (TYR973)  STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH (R)-5-(3- ((3-(6-METHOXYBENZO[D]ISOXAZOL-3-YL)-2-OXO-2,3-DIHYDRO-1H- BENZO[D]IMIDAZOL-1-YL)METHYL)PHENYL)-5-METHYLOXAZOLIDINE-2,4-DIONE  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION REGULATOR 
1r1k:D   (MET413) to   (TRP526)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO PONASTERONE A  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, HETERODIMER, ALPHA-HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
3hc6:A   (ASP359) to   (TRP469)  FXR WITH SRC1 AND GSK088  |   FXR, NUCLEAR RECEPTOR, GW4064, ALPHA-HELICAL SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL- BINDING, NUCLEUS, RECEPTOR, REPRESSOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1fby:B  (LEU1353) to  (GLU1456)  CRYSTAL STRUCTURE OF THE HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO 9-CIS RETINOIC ACID  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, RETINOID RECEPTOR, TRANSCRIPTION 
1r20:D   (MET413) to   (TRP526)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER ECR/USP BOUND TO THE SYNTHETIC AGONIST BYI06830  |   NUCLEAR RECEPTOR, HETERODIMER, ALPHA-HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
4jyh:B   (LEU298) to   (MET407)  CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH SELECTIVE AGONIST BMS948 [4-{[(8-PHENYLNAPHTHALEN-2-YL)CARBONYL]AMINO}BENZOIC ACID]  |   LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- AGONIST COMPLEX 
1fd0:A   (ASP309) to   (GLU417)  ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254  |   ISOTYPE SELECTIVITY, RETINOID LIGAND COMPLEXES, DRUG DESIGN, ANTIPARALLEL ALPHA-HELICAL SANDWICH FOLD, CH...O HYDROGEN BOND, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION 
3u9q:A   (MET364) to   (TYR473)  LIGAND BINDING DOMAIN OF PPARGAMMA COMPLEXED WITH DECANOIC ACID AND PGC-1A PEPTIDE  |   NUCLEAR RECEPTOR, ADIPOGENESIS, RXRA, NUCLEUS, TRANSCRIPTION 
1r5k:A   (MET421) to   (ASP545)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH GW5638  |   ALPHA HELIX, HELICAL SANDWICH, DNA BINDING PROTEIN 
2v0v:A   (ASP481) to   (LYS576)  CRYSTAL STRUCTURE OF REV-ERB BETA  |   ZINC, RECEPTOR, REPRESSOR, ZINC-FINGER, DNA-BINDING, CONSTITUTIVE REPRESSION, TRANSCRIPTION REGULATION, ORPHAN RECEPTOR, A-HELICAL SANDWICH, TRANSCRIPTION, METAL-BINDING, NUCLEAR PROTEIN 
1fm9:D   (ARG357) to   (TYR473)  THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION 
2ewp:A   (LEU343) to   (ILE438)  CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR-3 (ERR-GAMMA) LIGAND BINDING DOMAIND WITH TAMOXIFEN ANALOG GSK5182  |   TAMOXIFEN, ERR, ESTROGEN RELATED RECEPTOR, ORPHAN RECEPTOR, TRANSCRIPTION 
4yt1:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMMA SELECTIVE SYNTHETIC PARTIAL AGONIST MEKT76  |   NUCLEAR RECEPTOR, TRANSCRIPTION 
4yt1:B   (LYS358) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMMA SELECTIVE SYNTHETIC PARTIAL AGONIST MEKT76  |   NUCLEAR RECEPTOR, TRANSCRIPTION 
3hlv:A   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND 16-ALPHA-HYDROXY-ESTRONE ((8S,9R,13S,14R, 16R)-3,16-DIHYDROXY-13-METHYL-7,8,9,11,12,14,15, 16-OCTAHYDRO-6H- CYCLOPENTA[A]PHENANTHREN-17-ONE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HYDROXY-ESTRONE, ALTERNATIVE SPLICING, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, HORMONE, NUCLEAR RECEPTOR 
3hm1:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL- 7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE)  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, ESTRONE, ALTERNATIVE SPLICING, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, HORMONE, NUCLEAR RECEPTOR 
3hm1:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTRONE ((8R,9S,13S,14S)-3-HYDROXY-13-METHYL- 7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-17-ONE)  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, ESTRONE, ALTERNATIVE SPLICING, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, HORMONE, NUCLEAR RECEPTOR 
1rdt:D   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHA LIGAND BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER  |   HORMONE, RECEPTOR, POLYMORPHISM, HORMONE/GROWTH FACTOR COMPLEX 
2f4b:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH AN AGONIST  |   PPAR, TRANSCRIPTION ACTIVATOR 
2f4b:B   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH AN AGONIST  |   PPAR, TRANSCRIPTION ACTIVATOR 
3ho0:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A NEW ARYLOXY-3PHENYLPROPANOIC ACID  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3ho0:B   (ARG357) to   (LYS474)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A NEW ARYLOXY-3PHENYLPROPANOIC ACID  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1g1u:D   (GLY343) to   (GLY443)  THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND  |   CRYSTAL STRUCTURE, RXRALPHA LIGAND BINDING DOMAIN, TETRAMER, ABSENCE OF LIGAND, TRANSCRIPTION 
2fai:A   (VAL422) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-2M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2fai:B   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-2M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
3hod:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A NEW ARYLOXY-3PHENYLPROPANOIC ACID  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3up0:A   (HIS583) to   (PHE682)  NUCLEAR RECEPTOR DAF-12 FROM HOOKWORM ANCYLOSTOMA CEYLANICUM IN COMPLEX WITH (25S)-DELTA7-DAFACHRONIC ACID  |   NEMATODE, STEROID BINDING PROTEIN-TRANSCRIPTION COMPLEX 
3up0:B   (HIS583) to   (PHE682)  NUCLEAR RECEPTOR DAF-12 FROM HOOKWORM ANCYLOSTOMA CEYLANICUM IN COMPLEX WITH (25S)-DELTA7-DAFACHRONIC ACID  |   NEMATODE, STEROID BINDING PROTEIN-TRANSCRIPTION COMPLEX 
3uu7:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-A  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uua:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-AF  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uua:B   (GLY442) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-AF  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uuc:A   (MET421) to   (LEU544)  CRYSTAL STRUCTURE OF HERA-LBD (WT) IN COMPLEX WITH BISPHENOL-C  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uuc:B   (VAL422) to   (MET543)  CRYSTAL STRUCTURE OF HERA-LBD (WT) IN COMPLEX WITH BISPHENOL-C  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uuc:C   (MET421) to   (ASP545)  CRYSTAL STRUCTURE OF HERA-LBD (WT) IN COMPLEX WITH BISPHENOL-C  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uuc:D   (MET421) to   (GLU542)  CRYSTAL STRUCTURE OF HERA-LBD (WT) IN COMPLEX WITH BISPHENOL-C  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
1s0x:A   (ASP398) to   (ARG500)  CRYSTAL STRUCTURE OF THE HUMAN RORALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH CHOLESTEROL SULFATE AT 2.2A  |   THREE-LAYERED ALPHA HELICAL SANDWICH, NUCLEAR HORMONE RECEPTOR, ORPHAN RECEPTOR, LIGAND BINDING DOMAIN, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
3hv0:A   (ASN481) to   (ASN579)  TRYPTOPHANYL-TRNA SYNTHETASE FROM CRYPTOSPORIDIUM PARVUM  |   TRNA-LIGASE, ATP-BINDING, AMINOACYL-TRNA SYNTHETASE, LIGASE, NUCLEOTIDE-BINDING, PROTEIN BIOSYNTHESIS, STRUCTURAL GENOMICS, MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA, MSGPP 
3hv0:B   (ASN481) to   (ASN579)  TRYPTOPHANYL-TRNA SYNTHETASE FROM CRYPTOSPORIDIUM PARVUM  |   TRNA-LIGASE, ATP-BINDING, AMINOACYL-TRNA SYNTHETASE, LIGASE, NUCLEOTIDE-BINDING, PROTEIN BIOSYNTHESIS, STRUCTURAL GENOMICS, MEDICAL STRUCTURAL GENOMICS OF PATHOGENIC PROTOZOA, MSGPP 
3hvl:A   (MET323) to   (PHE429)  TETHERED PXR-LBD/SRC-1P COMPLEXED WITH SR-12813  |   PXR, SRC-1, TETHERED, ENGINEERED, DRUG-DRUG INTERACTIONS, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, TRANSFERASE 
1s9p:D   (LEU343) to   (GLY442)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH DIETHYLSTILBESTROL  |   LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION 
1s9q:A   (LEU343) to   (GLY442)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION 
3v3e:B   (TRP151) to   (LEU265)  CRYSTAL STRUCTURE OF THE HUMAN NUR77 LIGAND-BINDING DOMAIN  |   ORPHAN NUCLEAR RECEPTOR, TRANSCRIPTION 
3v49:A   (TYR781) to   (SER888)  STRUCTURE OF AR LBD WITH ACTIVATOR PEPTIDE AND SARM INHIBITOR 1  |   DIARYLHYDANTOIN, SYNTHESIS, SARM, ANTIANDROGEN, LIGAND BINDING DOMAIN, TESTOSTERONE, DIHYDROTESTOSTERONE, TRANSCRIPTION, SARM (SELECTIVE ANDROGEN RECEPTOR MODULATOR) 
3v4a:A   (MET780) to   (SER888)  STRUCTURE OF AR LBD WITH ACTIVATOR PEPTIDE AND SARM INHIBITOR 2  |   DIARYLHYDANTOIN, SYNTHESIS, ANTIANDROGEN, ANDROGEN RECEPTOR, TESTOSTERONE, SELECTIVE ANDROGEN RECEPTOR MODULATOR, DIHYDROTESTOSTERONE, TRANSCRIPTION 
2fvj:A   (MET364) to   (TYR473)  A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITS PPARG-COACTIVATOR-1 ALPHA (PGC1A) BUT POTENTIATES INSULIN SIGNALING IN VITRO  |   NUCLEAR RECEPTOR LBD, ALPHA HELICAL SANDWICH, SIGNALING PROTEIN 
3v7o:A    (SER41) to   (TYR124)  CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF EBOLA VIRUS VP30 (STRAIN RESTON-89)  |   EBOLA, VP30, SSGCID, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SMT, NUCLEOPROTEIN, TRANSCRIPTION 
2g0g:A   (ARG357) to   (TYR473)  STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES  |   PPAR, TRANSCRIPTION ACTIVATOR 
2g0g:B   (ARG357) to   (LYS474)  STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES  |   PPAR, TRANSCRIPTION ACTIVATOR 
2g0h:A   (ARG357) to   (LYS474)  STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES  |   PPAR, TRANSCRIPTION ACTIVATOR 
2g0h:B   (GLU365) to   (TYR473)  STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPAR PARTIAL AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN VIVO BIOLOGICAL ACTIVITIES  |   PPAR, TRANSCRIPTION ACTIVATOR 
2g44:A   (VAL422) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M-G AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2g44:B   (VAL422) to   (LEU544)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-1M-G AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
3v9t:A   (PHE360) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR  |   THREE-LAYERED ALPHA-HELICAL SANDWICH, TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
3v9v:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR  |   THREE-LAYERED ALPHA-HELICAL SANDWICH, TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
3v9y:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR  |   THREE-LAYERED ALPHA-HELICAL SANDWICH, TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
2g5o:A   (MET421) to   (ALA546)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2- (BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2g5o:B   (MET421) to   (ASP545)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 2- (BUT-1-ENYL)-17BETA-ESTRADIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2vsr:A   (ARG357) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S)-HODE  |   TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, POLYMORPHISM, TRANSCRIPTION, ZINC, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDISED FATTY ACID, TRANSCRIPTION FACTOR, METAL-BINDING, PHOSPHOPROTEIN, DISEASE MUTATION 
2vst:A   (ARG357) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S)- HODE  |   TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, POLYMORPHISM, TRANSCRIPTION, ZINC, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDISED FATTY ACID, TRANSCRIPTION FACTOR, METAL-BINDING, PHOSPHOPROTEIN, DISEASE MUTATION 
2vv2:A   (ARG357) to   (LYS474)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-HEPA  |   TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, NUCLEAR RECEPTOR, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, POLYMORPHISM, TRANSCRIPTION, ZINC, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDISED FATTY ACID, TRANSCRIPTION FACTOR, METAL-BINDING, PHOSPHOPROTEIN, DISEASE MUTATION 
2vv4:A   (ARG357) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXOOTE  |   RECEPTOR, NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, OXIDISED FATTY ACID, TRANSCRIPTION FACTOR 
1gwq:A   (MET421) to   (ALA546)  HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSACTIVATION, AGONIST, AF2 COACTIVATOR , RECEPTOR, ACTIVATOR, TRANSCRIPTI REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC FINGER, STER BINDING, PHOSPHORYLATION, POLYMORPHISM, ALTERNATIVE SPLICIN 
1gwq:B   (MET421) to   (ALA546)  HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSACTIVATION, AGONIST, AF2 COACTIVATOR , RECEPTOR, ACTIVATOR, TRANSCRIPTI REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC FINGER, STER BINDING, PHOSPHORYLATION, POLYMORPHISM, ALTERNATIVE SPLICIN 
1gwx:A   (LYS358) to   (TYR473)  MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS  |   PPAR, FATTY ACIDS, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD 
1gwx:B   (ARG357) to   (TYR473)  MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS  |   PPAR, FATTY ACIDS, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD 
3ia6:A   (ARG357) to   (TYR473)  X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A PPAR GAMMA/ALPHA DUAL AGONIST  |   PROTEIN-LIGAND COMPLEX, DUAL SPECIFICITY, INHIBITOR, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3vhw:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 4-MP  |   HORMONE RECEPTOR, TRANSCRIPTION 
3vi8:A   (LYS349) to   (ARG465)  HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST APHM13  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION 
3vji:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH JKPL53  |   TRANSCRIPTION FACTOR, TRANSCRIPTION 
3vji:B   (LYS358) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH JKPL53  |   TRANSCRIPTION FACTOR, TRANSCRIPTION 
4l36:A   (ALA138) to   (LEU227)  CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE  |   CYTOCHROME P450, DIRECT NITRATION, INDOLYL, L-TRYPTOPHAN, L-4- NITROTRYPTOPHAN, HEME, OXIDOREDUCTASE 
3vjs:A   (THR302) to   (LEU410)  VITAMIN D RECEPTOR COMPLEX WITH A CARBORANE COMPOUND  |   NUCLEAR RECEPTOR, SYNTHETIC AGONIST, CARBORANE, TRANSCRIPTION 
1t65:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FORM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX 2 BOUND IN A NON- HELICAL CONFORMATION  |   ANDROGEN RECEPTOR LIGAND BINDING DOMAIN GRIP1 NR BOX2 COACTIVATORS CRYSTAL STRUCTURE NON-HELICAL, HORMONE/GROWTH FACTOR COMPLEX 
1t63:A   (MET780) to   (SER888)  CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN WITH DHT AND A PEPTIDE DERIVED FROM ITS PHYSIOLOGICAL COACTIVATOR GRIP1 NR BOX3  |   ANDROGEN RECEPTOR LIGAND BINDING DOMAIN GRIP1 NR BOXES COACTIVATORS DHT CRYSTAL STRUCTURE, HORMONE/GROWTH FACTOR COMPLEX 
4zn9:A   (MET421) to   (VAL533)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONATE (OBHS)  |   PROTEIN LIGAND COMPLEX, TRANSCRIPTION 
4zns:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-FLUORO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znt:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-BROMO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znt:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-BROMO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znv:A   (VAL422) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHOXY-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znv:B   (MET421) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHOXY-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znw:A   (VAL422) to   (VAL533)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 4-BROMO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
2gp7:D   (ASP344) to   (LYS457)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, TRANSCRIPTION 
1t7f:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH A LXXLL MOTIF  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING DOMAIN, AF-2, ANDROGEN, TESTOSTERONE, DHT, ALPHA-HELICAL SANDWICH, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
2gpo:A   (LEU343) to   (VAL458)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH A SYNTHETIC PEPTIDE FROM RIP140  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, RIP140, TRANSCRIPTION 
2gpu:A   (LEU343) to   (LEU454)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, TRANSCRIPTION 
2gpv:A   (LEU343) to   (GLY442)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, SMRT, TAMOXIFEN, TRANSCRIPTION 
1t7t:A   (TYR781) to   (GLN902)  CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH 5-ALPHA DIHYDROTESTOSTERONE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING DOMAIN, AF-2, ANDROGEN, TESTOSTERONE, DHT, ALPHA-HELICAL SANDWICH, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
2gtk:A   (ARG357) to   (TYR473)  STRUCTURE-BASED DESIGN OF INDOLE PROPIONIC ACIDS AS NOVEL PPARAG CO-AGONISTS  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR 
4lbd:A   (LEU307) to   (GLU417)  LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS961  |   NUCLEAR RECEPTOR, RETINOIC ACID RECEPTOR, ALL-TRANS RETINOIC ACID, LIGAND-BINDING DOMAIN, COMPLEX, HOLO FORM, TRANSCRIPTION REGULATION, LIGAND-DEPENDENT, ACTIVE CONFORMATION, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
2gwx:A   (LYS358) to   (TYR473)  MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS  |   PPAR, FATTY ACIDS, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD 
2gwx:B   (ARG357) to   (MET476)  MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS  |   PPAR, FATTY ACIDS, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD 
3ipu:A   (VAL333) to   (TRP443)  X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA  |   NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, ISOPEPTIDE BOND, PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION 
3ipu:B   (VAL333) to   (TRP443)  X-RAY STRUCTURE OF BENZISOXAZOLE UREA SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA  |   NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, ISOPEPTIDE BOND, PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION 
1hg4:A   (SER383) to   (ALA497)  ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING 
1hg4:B   (SER383) to   (ALA497)  ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING 
1hg4:F   (SER383) to   (ALA497)  ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING 
2ham:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF VDR LBD COMPLEXED TO 2ALPHA-PROPYL- CALCITRIOL  |   ALPHA-HELICAL SANDWICH, GENE REGULATION 
2har:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2 ALPHA-(3- HYDROXY-1-PROPOXY) CALCITRIOL  |   ALPHA HELICAL SANDWICH, GENE REGULATION 
3vn2:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA COMPLEXED WITH TELMISARTAN  |   SIGNALING PROTEIN 
2hc4:A   (THR334) to   (LEU440)  CRYSTAL STRUCTURE OF THE LBD OF VDR OF DANIO RERIO IN COMPLEX WITH CALCITRIOL  |   ALPHA HELICAL SANDWICH, GENE REGULATION 
2hfp:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPAR GAMMA WITH N-SULFONYL-2-INDOLE CARBOXAMIDE LIGANDS  |   PPAR PPARGAMMA LBD, TRANSCRIPTION 
3ixp:D   (MET413) to   (TRP526)  CRYSTAL STRUCTURE OF THE ECDYSONE RECEPTOR BOUND TO BYI08346  |   ANTI-PARALLEL ALPHA-HELICES, TRANSCRIPTION, TRANSCRIPTION REGULATION 
3vso:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MEKT21  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3vsp:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MEKT28  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3vt3:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION  |   TRANSCRIPTION, HORMONE RECEPTOR 
3vt4:A   (THR302) to   (THR411)  CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION  |   TRANSCRIPTION, HORMONE RECEPTOR 
3vt5:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION  |   TRANSCRIPTION, HORMONE RECEPTOR 
3vt6:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURE OF RAT VDR-LBD WITH 2-SUBSTITUTED-16-ENE-22-THIA- 1ALPHA,25-DIHYDROXY-26,27-DIMETHYL-19-NORVITAMIN D3  |   TRANSCRIPTION, HORMONE RECEPTOR 
3vt8:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURES OF RAT VDR-LBD WITH W282R MUTATION  |   TRANSCRIPTION, HORMONE RECEPTOR 
3vtb:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO A PARTIAL AGONIST 25-ADAMANTYL-23-YNE-19-NORVITAMMIN D ADTK1  |   TRANSCRIPTION, HORMONE RECEPTOR 
3w0a:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
3w0c:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
3w0g:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS  |   GENE REGULATION, TRANSCRIPTION 
3w0i:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS  |   GENE REGULATION, TRANSCRIPTION 
3w0y:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
4lto:A   (ALA151) to   (SER285)  BACTERIAL SODIUM CHANNEL IN HIGH CALCIUM, I222 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4lto:C   (GLY149) to   (SER285)  BACTERIAL SODIUM CHANNEL IN HIGH CALCIUM, I222 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltp:A   (GLY149) to   (ARG284)  BACTERIAL SODIUM CHANNEL IN HIGH CALCIUM, I222 SPACE GROUP, CRYSTAL 2  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:A   (ILE150) to   (ARG284)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:B   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:C   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:D   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:H   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:I   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:J   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
4ltq:K   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL IN LOW CALCIUM, P42 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
2hvc:A   (TYR781) to   (SER888)  THE CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN (LBD) OF HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH A SELECTIVE MODULATOR LGD2226  |   COMPLEXED WITH LGD2226, DNA-BINDING, STEROID-BINDING, LIGAND BINDING PROTEIN 
1i7g:A   (ARG348) to   (TYR468)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242  |   ANTI PARALLEL HELIX SANDWICH, TRANSCRIPTION 
2hwq:A   (ARG357) to   (TYR473)  STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS  |   PPAR, LIGAND BINDING PROTEIN 
2hwr:A   (LYS358) to   (TYR473)  STRUCTURAL BASIS FOR THE STRUCTURE-ACTIVITY RELATIONSHIPS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS  |   PPAR, LIGAND BINDING PROTEIN 
1i7i:A   (ARG357) to   (LYS474)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242  |   ANTI PARALLEL HELIX SANDWICH, TRANSCRIPTION 
1i7i:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242  |   ANTI PARALLEL HELIX SANDWICH, TRANSCRIPTION 
1ie8:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO KH1060  |   VDR, KH1060, GENE REGULATION 
3w5p:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES  |   ZINC-FINGER, NUCLEAR RECEPTOR-AGONIST COMPLEX, TRANSCRIPTION, RECEPTOR,TRANSCRIPTION REGULATION, ACTIVATOR, DNA-BINDING, METAL- BINDING, PHOSPHOPROTEIN, NUCLEUS 
3w5t:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES  |   ZINC-FINGER, NUCLEAR RECEPTOR-AGONIST COMPLEX, TRANSCRIPTION, RECEPTOR, TRANSCRIPTION REGULATION, ACTIVATOR, DNA-BINDING, METAL- BINDING, PHOSPHOPROTEIN, NUCLEUS 
3w5r:A   (THR302) to   (THR411)  CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES  |   ZINC-FINGER, NUCLEAR RECEPTOR-AGONIST COMPLEX, TRANSCRIPTION, RECEPTOR, TRANSCRIPTION REGULATION, ACTIVATOR ,DNA-BINDING, METAL- BINDING, PHOSPHOPROTEIN, NUCLEUS 
2i4j:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE AGONIST LT160 (UREIDOFIBRATE DERIVATIVE)  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA- SHEET, TRANSCRIPTION 
1uhl:B   (GLU334) to   (TRP443)  CRYSTAL STRUCTURE OF THE LXRALFA-RXRBETA LBD HETERODIMER  |   LIGAND-BINDING DOMAIN, DNA BINDING PROTEIN 
2i4p:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). STRUCTURE OBTAINED FROM CRYSTALS OF THE APO-FORM SOAKED FOR 30 DAYS.  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA- SHEET, TRANSCRIPTION 
2i4z:A   (ARG357) to   (LYS474)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE PARTIAL AGONIST LT127 (UREIDOFIBRATE DERIVATIVE). THIS STRUCTURE HAS BEEN OBTAINED FROM CRYSTALS SOAKED FOR 6 HOURS.  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA- SHEET, TRANSCRIPTION 
5a86:A   (PRO322) to   (LEU428)  STRUCTURE OF PREGNANE X RECEPTOR IN COMPLEX WITH A SPHINGOSINE 1-PHOSPHATE RECEPTOR 1 ANTAGONIST  |   SIGNALING PROTEIN, PXR LIGAND, PXR AGONIST, CYP3A4 INDUCTION, NUCLEAR RECEPTOR 
5a86:B   (PRO322) to   (LEU428)  STRUCTURE OF PREGNANE X RECEPTOR IN COMPLEX WITH A SPHINGOSINE 1-PHOSPHATE RECEPTOR 1 ANTAGONIST  |   SIGNALING PROTEIN, PXR LIGAND, PXR AGONIST, CYP3A4 INDUCTION, NUCLEAR RECEPTOR 
1ilg:A   (PRO322) to   (PHE429)  CRYSTAL STRUCTURE OF APO HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN  |   NUCLEAR RECEPTOR, MULTIPLE BINDING MODES, XENOBIOTIC, PROMISCUOUS, APO, GENE REGULATION 
1upv:A   (GLN346) to   (TRP457)  CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST  |   RECEPTOR, NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, LIVER X RECEPTOR, CRYSTAL STRUCTURE, TRANSCRIPTION FACTOR 
4mg5:A   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH CHLORDECONE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg5:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH CHLORDECONE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg6:A   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZYLBUTYLPHTALATE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg6:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZYLBUTYLPHTALATE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg7:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH FERUTININE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg8:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALANOL  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg9:A   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BUTYLPARABEN  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg9:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BUTYLPARABEN  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mga:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH 4-TERT- OCTYLPHENOL  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mgb:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH TCBPA  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mgb:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH TCBPA  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
2iog:A   (VAL422) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 11F  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE 
4mgc:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZOPHENONE-2  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mgc:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZOPHENONE-2  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mgd:A   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH HPTE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mgd:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH HPTE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3wj4:A   (PRO366) to   (LYS474)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIBUTYLTIN  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION 
3wj4:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIBUTYLTIN  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION 
3wj5:A   (ARG357) to   (LYS474)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPHENYLTIN  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION 
3wj5:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPHENYLTIN  |   PROTEIN-LIGAND COMPLEX, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION 
2j14:A   (LYS322) to   (TYR437)  3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2  |   TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, PPAR, ZINC, RECEPTOR, ACTIVATOR, FATTY ACIDS, NUCLEAR PROTEIN, ALTERNATIVE SPLICING, ZINC-FINGER, DNA-BINDING, METAL-BINDING 
2j14:B   (LYS322) to   (LYS438)  3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2  |   TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, PPAR, ZINC, RECEPTOR, ACTIVATOR, FATTY ACIDS, NUCLEAR PROTEIN, ALTERNATIVE SPLICING, ZINC-FINGER, DNA-BINDING, METAL-BINDING 
5avi:A   (VAL333) to   (TRP443)  CRYSTAL STRUCTURE OF LXRALPHA IN COMPLEX WITH TERT-BUTYL BENZOATE ANALOG, COMPOUND 4  |   AGONIST, COMPLEX, TRANSCRIPTION 
5avi:C   (VAL333) to   (TRP443)  CRYSTAL STRUCTURE OF LXRALPHA IN COMPLEX WITH TERT-BUTYL BENZOATE ANALOG, COMPOUND 4  |   AGONIST, COMPLEX, TRANSCRIPTION 
5avl:A   (VAL333) to   (TRP443)  CRYSTAL STRUCTURE OF LXRALPHA IN COMPLEX WITH TERT-BUTYL BENZOATE ANALOG, COMPOUND 32B  |   AGONIST, COMPLEX 
2xhs:A   (LEU912) to  (ALA1023)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF FUSHI TARAZU FACTOR 1 OF DROSOPHILA MELANOGASTER.  |   TRANSCRIPTION 
2j7x:A   (ILE328) to   (ASN451)  STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5  |   ZINC-FINGER, NUCLEAR RECEPTOR, PHOSPHORYLATION, STEROID-BINDING, GLYCOPROTEIN, TRANSCRIPTION REGULATION, TRANSCRIPTION, 
2xkw:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE  |   TRANSCRIPTION, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, GENE REGULATION, THIAZOLIDINEDIONE 
3wwr:A   (PRO312) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1-((((1S,2R,6R,Z)-2,6-DIHYDROXY-4-((E)-2-((1R, 3AS,7AR)-1-((R)-6-HYDROXY-6-METHYLHEPTAN-2-YL)-7A-METHYLHEXAHYDRO-1H- INDEN-4(2H)-YLIDENE)ETHYLIDENE)-3-METHYLENECYCLOHEXYL)OXY)METHYL) CYCLOPROPANECARBONITRILE  |   HORMONE RECEPTOR, TRANSCRIPTION 
5azt:A   (LYS349) to   (TYR464)  TERNARY COMPLEX OF HPPARALPHA LIGAND BINDING DOMAIN, 17-OXODHA AND A SRC1 PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, ZINC-FINGER, DNA BINDING, TRANSCRIPTION, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDIZED FATTY ACID, TRANSCRIPTION FACTOR, AGONIST, DUAL AGONIST, COVALENT, PPRE, NUCLEAR, CO-ACTIVATOR, DNA BINDING PROTEIN 
5azt:B   (LYS349) to   (TYR464)  TERNARY COMPLEX OF HPPARALPHA LIGAND BINDING DOMAIN, 17-OXODHA AND A SRC1 PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, ZINC-FINGER, DNA BINDING, TRANSCRIPTION, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDIZED FATTY ACID, TRANSCRIPTION FACTOR, AGONIST, DUAL AGONIST, COVALENT, PPRE, NUCLEAR, CO-ACTIVATOR, DNA BINDING PROTEIN 
5azv:A   (GLU365) to   (TYR473)  CRYSTAL STRUCTURE OF HPPARGAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 17-OXODHA  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, ZINC-FINGER, DNA BINDING, TRANSCRIPTION, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDIZED FATTY ACID, TRANSCRIPTION FACTOR, AGONIST, DUAL AGONIST, COVALENT, PPRE, NUCLEAR, DNA BINDING PROTEIN 
3x1h:B   (ARG357) to   (LYS474)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-OXO- TRICOSAHEXAENOIC ACID  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION, OBESITY 
3x1i:A   (LYS358) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXO- TETRACOSAHEXAENOIC ACID  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION, OBESITY 
3x1i:B   (LYS358) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXO- TETRACOSAHEXAENOIC ACID  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND BINDING DOMAIN, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION, OBESITY 
3x31:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 7,8-CIS-14-EPI-1A,25-DIHYDROXY-19-NORVITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
3x36:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 7,8-CIS-1A,25-DIHYDROXY-19-NORVITAMIN D3  |   TRANSCRIPTION, HORMONE RECEPTOR 
2xyj:A   (ARG321) to   (MET440)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   TRANSCRIPTION 
2xyj:B   (ARG321) to   (MET440)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   TRANSCRIPTION 
2xyw:A   (LYS322) to   (TYR437)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, RECEPTOR, ACTIVATOR, ZINC-FINGER 
2xyw:B   (LYS322) to   (LYS438)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, RECEPTOR, ACTIVATOR, ZINC-FINGER 
2xyx:A   (ILE328) to   (TYR437)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, RECEPTOR, ACTIVATOR, ZINC-FINGER 
2xyx:B   (ILE328) to   (MET440)  NOVEL SULFONYLTHIADIAZOLES WITH AN UNUSUAL BINDING MODE AS PARTIAL DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA-DELTA AGONISTS WITH HIGH POTENCY AND IN-VIVO EFFICACY  |   DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, RECEPTOR, ACTIVATOR, ZINC-FINGER 
1k4w:A   (SER335) to   (THR440)  X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ROR BETA LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION  |   LIGAND-BINDING DOMAIN, ALPHA-HELICAL SANDWICH, TRANSCRIPTIONALLY ACTIVE CONFORMATION, HORMONE/GROWTH FACTOR COMPLEX 
1k74:D   (PRO359) to   (TYR473)  THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN PPARGAMMA AND RXRALPHA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH GW409544 AND 9-CIS RETINOIC ACID AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND GW409544 AND COACTIVATOR PEPTIDES, TRANSCRIPTION 
1k7l:A   (MET355) to   (ARG465)  THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE.  |   THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A COACTIVATOR PEPTIDE, TRANSCRIPTION 
1k7l:C   (ARG348) to   (TYR464)  THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE.  |   THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A COACTIVATOR PEPTIDE, TRANSCRIPTION 
1k7l:E   (MET355) to   (ARG465)  THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A CO-ACTIVATOR PEPTIDE.  |   THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PPARALPHA LIGAND BINDING DOMAIN BOUND WITH GW409544 AND A COACTIVATOR PEPTIDE, TRANSCRIPTION 
3zqt:A   (MET780) to   (GLN902)  TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING  |   TRANSCRIPTION, SMALL MOLECULE INHIBITOR 
2yat:A   (ASP426) to   (ALA546)  CRYSTAL STRUCTURE OF ESTRADIOL DERIVED METAL CHELATE AND ESTROGEN RECEPTOR-LIGAND BINDING DOMAIN COMPLEX  |   TRANSCRIPTION 
1kkq:A   (LYS349) to   (TYR468)  CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF  |   NUCLEAR COREPRESSOR NUCLEAR HORMONE RECEPTORS ANTAGONIST, TRANSCRIPTION 
1kkq:C   (LYS349) to   (MET467)  CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF  |   NUCLEAR COREPRESSOR NUCLEAR HORMONE RECEPTORS ANTAGONIST, TRANSCRIPTION 
1kkq:D   (PHE351) to   (TYR468)  CRYSTAL STRUCTURE OF THE HUMAN PPAR-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN ANTAGONIST GW6471 AND A SMRT COREPRESSOR MOTIF  |   NUCLEAR COREPRESSOR NUCLEAR HORMONE RECEPTORS ANTAGONIST, TRANSCRIPTION 
2lvj:A    (ARG10) to    (PHE77)  SOLUTION STRUCTURE OF HEMI-MG-BOUND PHL P 7  |   EF-HAND PROTEIN, MAGNESIUM-BINDING PROTEIN, ALLERGEN 
1knu:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST  |   PPAR, NUCLEAR RECEPTOR, TRANSCRIPTION, GENE REGULATION, AGONIST COMPLEX, DNA BINDING PROTEIN 
1knu:B   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETIC AGONIST  |   PPAR, NUCLEAR RECEPTOR, TRANSCRIPTION, GENE REGULATION, AGONIST COMPLEX, DNA BINDING PROTEIN 
1x7r:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN RECEPTOR ALPHA, ER-ALPHA, ESTROGEN, NUCLEAR RECEPT TRANSCRIPTION FACTOR, AGONIST 
2npa:A   (MET355) to   (ARG465)  THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID  |   PROTEIN-AGONIST COMPLEX, TRANSCRIPTION 
2npa:C   (MET355) to   (ARG465)  THE CRYSTAL STRUCTURE OF THE HUMAN PPARAPLPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A A-HYDROXYIMINO PHENYLPROPANOIC ACID  |   PROTEIN-AGONIST COMPLEX, TRANSCRIPTION 
2yja:B   (MET421) to   (LEU549)  STAPLED PEPTIDES BINDING TO ESTROGEN RECEPTOR ALPHA.  |   HORMONE RECEPTOR-PEPTIDE COMPLEX 
1l2i:A   (MET421) to   (ALA546)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, AGONIST, COACTIVATOR, TRANSCRIPTION RECEPTOR/COACTIVATOR COMPLEX 
1l2i:B   (MET421) to   (HIS547)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ESTROGEN, AGONIST, COACTIVATOR, TRANSCRIPTION RECEPTOR/COACTIVATOR COMPLEX 
2ylp:A   (TYR781) to   (SER888)  TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING  |   HORMONE RECEPTOR, BINDING FUNCTION 3 
2nv7:B   (ILE373) to   (ALA497)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
2nxx:A   (LEU296) to   (GLY403)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A  |   HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX 
2nxx:B   (TYR292) to   (GLU402)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A  |   HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX 
2nxx:C   (LEU296) to   (GLY403)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A  |   HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX 
2nxx:D   (TYR292) to   (GLY403)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE T.CASTANEUM (COLEOPTERA) HETERODIMER ECRUSP BOUND TO PONASTERONE A  |   HORMONE RECEPTOR, APO AND HOLO LIGAND BINDING POCKET, HORMONE/GROWTH FACTOR COMPLEX 
1xj7:A   (MET780) to   (SER888)  COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE  |   ANDROGEN RECEPTOR COACTIVATORS LXXLL MOTIF, HORMONE/GROWTH FACTOR COMPLEX 
4a4v:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN 2  |   RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE 
4oj4:A   (ARG357) to   (TYR477)  CRYSTAL STRUCTURE OF V290M PPARGAMMA MUTANT IN COMPLEX WITH DICLOFENAC  |   MAINLY ALPHA HELIX, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, RXR, TRANSCRIPTION 
1xnn:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF THE RAT ANDROGEN RECEPTOR LIGAND BINDING DOMAIN T877A MUTANT COMPLEX WITH (3A-ALPHA-,4- ALPHA 7-ALPHA-,7A-ALPHA-)-3A,4,7,7A-TETRAHYDRO-2-(4-NITRO- 1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE.  |   ANDROGEN RECEPTOR, STEROID RECEPTOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, LIGAND-BINDING DOMAIN, HORMONE/GROWTH FACTOR COMPLEX 
1m13:A   (PRO322) to   (PHE429)  CRYSTAL STRUCTURE OF THE HUMAN PREGANE X RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH HYPERFORIN, A CONSTITUENT OF ST. JOHN'S WORT  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
4okx:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF W741L-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE  |   ALPHA-HELIX, HORMONE/GROWTH FACTOR RECEPTOR, PHOSPHORYLATION, HORMONE RECEPTOR-PEPTIDE COMPLEX, SIGNAL TRANSDUCTION 
1xp1:A   (MET421) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
1xp6:A   (MET421) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
1xpc:A   (MET421) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
1xq3:A   (TYR781) to   (GLY909)  CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN BOUND WITH R1881  |   CRYSTAL STRUCTURE; HUMAN ANDROGEN RECEPTOR LIGAND BINDING DOMAIN; R1881, TRANSCRIPTION 
4oni:B   (ALA422) to   (ALA538)  STRUCTURE OF HUMAN ORPHAN RECEPTOR LRH1 BOUND TO TWO BACTERIAL PHOSPHOLIPIDS  |   ALPHA HELICAL SANDWICH FOLD, NUCLEAR RECEPTOR, CO-FACTOR BINDING, NUCLEAR PROTEIN 
2zk0:A   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk0:B   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk1:A   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14- PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk2:A   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH GLUTATHION CONJUGATED 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk2:B   (MET364) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH GLUTATHION CONJUGATED 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk3:A   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 8-OXO- EICOSATETRAENOIC ACID  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk3:B   (PRO359) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 8-OXO- EICOSATETRAENOIC ACID  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk5:A   (GLU365) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH NITRO-233  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk5:B   (PRO359) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH NITRO-233  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zk6:A   (GLU365) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH C8-BODIPY  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2zk6:B   (PRO359) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH C8-BODIPY  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3kdt:A   (LYS349) to   (ARG465)  CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATEDECEPTOR ALPHA (PPARALPHA) COMPLEX WITH N-3-((2-(4-CHLOROPHENYL)-5-METHYL-1,3- OXAZOL-4-YL)METHOXY)BENZYL)-N-(METHOXYCARBONYL)GLYCINE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION REGULATION, ACTIVATOR, DNA- BINDING, LIPID-BINDING, RECEPTOR, TRANSCRIPTION, HORMONE RECEPTOR 
3kdu:A   (MET355) to   (ARG465)  CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATEDECEPTOR ALPHA (PPARALPHA) COMPLEX WITH N-3-((2-(4-CHLOROPHENYL)-5-METHYL-1,3- OXAZOL-4-YL)METHOXY)BENZYL)-N-((4-METHYLPHENOXY)CARBONYL)GLYCINE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION REGULATION, ACTIVATOR, DNA- BINDING, LIPID-BINDING, RECEPTOR, TRANSCRIPTION, HORMONE RECEPTOR 
3kdu:B   (MET355) to   (TYR464)  CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATEDECEPTOR ALPHA (PPARALPHA) COMPLEX WITH N-3-((2-(4-CHLOROPHENYL)-5-METHYL-1,3- OXAZOL-4-YL)METHOXY)BENZYL)-N-((4-METHYLPHENOXY)CARBONYL)GLYCINE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION REGULATION, ACTIVATOR, DNA- BINDING, LIPID-BINDING, RECEPTOR, TRANSCRIPTION, HORMONE RECEPTOR 
3kfc:A   (VAL347) to   (ASP458)  COMPLEX STRUCTURE OF LXR WITH AN AGONIST  |   NUCLEAR RECEPTOR, LXR, LIVER X RECEPTOR, LXR AGONIST, LXR LIGAND, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3kfc:B   (GLN346) to   (TRP457)  COMPLEX STRUCTURE OF LXR WITH AN AGONIST  |   NUCLEAR RECEPTOR, LXR, LIVER X RECEPTOR, LXR AGONIST, LXR LIGAND, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3kfc:D   (GLN346) to   (TRP457)  COMPLEX STRUCTURE OF LXR WITH AN AGONIST  |   NUCLEAR RECEPTOR, LXR, LIVER X RECEPTOR, LXR AGONIST, LXR LIGAND, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2zmh:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM  |   NUCLEAR RECEPTOR-ANTAGONIST COMPLEX, DNA-BINDING, METAL- BINDING, NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR 
2znn:A   (LYS349) to   (ARG465)  HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP703  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2znp:A   (PHE374) to   (TYR473)  HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP204  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2znp:B   (LYS358) to   (TYR473)  HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP204  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2zno:A   (ARG357) to   (LYS474)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP703  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
1m7w:D   (SER253) to   (GLY367)  HNF4A LIGAND BINDING DOMAIN WITH BOUND FATTY ACID  |   TRANSCRIPTION FACTOR 
1xvp:D   (GLU237) to   (PRO341)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO  |   CAR, RXR, CITCO, SRC1, DNA BINDING PROTEIN 
1y0s:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331  |   PPAR, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
1y0s:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331  |   PPAR, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
2zvt:A   (ASP362) to   (LYS474)  CYS285SER MUTANT PPARGAMMA LIGAND-BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2zvt:B   (LYS358) to   (TYR473)  CYS285SER MUTANT PPARGAMMA LIGAND-BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14-PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
4ozt:E   (GLY406) to   (ASP517)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAINS OF THE BOVICOLA OVIS ECDYSONE RECEPTOR ECR/USP HETERODIMER (PONA CRYSTAL)  |   ECDYSONE RECEPTOR, USP, PONA, TRANSCRIPTION 
2zxm:A   (THR302) to   (THR411)  A NEW CLASS OF VITAMIN D RECEPTOR LIGANDS THAT INDUCE STRUCTURAL REARRANGEMENT OF THE LIGAND-BINDING POCKET  |   NUCLEAR RECEPTOR-ANTAGONIST COMPLEX, TRANSCRIPTION, DNA- BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR 
2zxn:A   (THR302) to   (LEU410)  A NEW CLASS OF VITAMIN D RECEPTOR LIGANDS THAT INDUCE STRUCTURAL REARRANGEMENT OF THE LIGAND-BINDING POCKET  |   NUCLEAR RECEPTOR-AGONIST COMPLEX, TRANSCRIPTION, DNA- BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR 
3kmg:A   (GLU365) to   (TYR473)  THE X-RAY CRYSTAL STRUCTURE OF PPAR-GAMMA IN COMPLEX WITH AN INDOLE DERIVATIVE MODULATOR, GSK538, AND AN SRC-1 PEPTIDE  |   PPAR-GAMMA, PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR, TELMISARTAN, DIABETES, MODULATOR, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3kmg:D   (GLU365) to   (TYR473)  THE X-RAY CRYSTAL STRUCTURE OF PPAR-GAMMA IN COMPLEX WITH AN INDOLE DERIVATIVE MODULATOR, GSK538, AND AN SRC-1 PEPTIDE  |   PPAR-GAMMA, PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR, TELMISARTAN, DIABETES, MODULATOR, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3kpz:A   (SER306) to   (VAL421)  CRYSTAL STRUCTURE OF A NOVEL VITAMIN D3 ANALOGUE, ZK203278 SHOWING DISSOCIATED PROFILE  |   NUCLEAR RECEPTOR, AGONIST, DNA-BINDING, TRANSCRIPTION REGULATION, TRANSCRIPTION-HORMONE COMPLEX 
3a2j:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR (H305F/H397F) LIGAND BINDING DOMAIN COMPLEXED WITH TEI-9647  |   HORMONE/GROWTH FACTOR RECEPTOR, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER, ACTIVATOR, DISEASE MUTATION, RECEPTOR, HORMONE RECEPTOR 
3a3z:X   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VDR LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND 2ALPHA-METHYL-AMCR277A(C23S)  |   TRANSCRIPTION, STRUCTURAL GENOMICS, SPINE2, STRUCTURAL PROTEOMICS IN EUROPE 2, GENE REGULATION 
3a40:X   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VDR LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND 2ALPHA-METHYL-AMCR277B(C23R)  |   TRANSCRIPTION, STRUCTURAL GENOMICS, SPINE2, STRUCTURAL PROTEOMICS IN EUROPE 2, GENE REGULATION 
1yim:A   (VAL422) to   (LEU544)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 4  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
3a78:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VDR LIGAND BINDING DOMAIN BOUND TO THE NATURAL METABOLITE 1ALPHA,25-DIHYDROXY-3-EPI-VITAMIN D3  |   TRANSCRIPTION, GENE REGULATION, DISEASE MUTATION, DNA-BINDING, METAL- BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION REGULATION, ZINC-FINGER 
1yje:A   (TRP481) to   (ASP593)  CRYSTAL STRUCTURE OF THE RNGFI-B LIGAND-BINDING DOMAIN  |   NGFI-B, NUR77, NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, NOVEL COREGULATOR INTERFACE, CELL-SPECIFIC, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, TRANSCRIPTION 
1mzn:A   (ALA344) to   (GLU456)  CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE  |   TRANSCRIPTION, NUCLEAR RECEPTOR, RETINOIC ACID RECEPTORS, AGONIST 
1ymt:A   (SER343) to   (ALA459)  MOUSE SF-1 LBD  |   NUCLEAR RECEPTOR, SF-1, LIGAND-BINDING DOMAIN, LIGAND, PHOSPHATIDYL GLYCEROL, CO-REPRESSOR PEPTIDE, TRANSCRIPTION 
1yok:A   (ALA422) to   (HIS537)  CRYSTAL STRUCTURE OF HUMAN LRH-1 BOUND WITH TIF-2 PEPTIDE AND PHOSPHATIDYLGLYCEROL  |   LRH-1, TIF-1, PHOSPHATIDYLGLYCEROL, TRANSCRIPTION 
1yow:A   (LEU343) to   (GLN457)  HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR PEPTIDE  |   STEROIDOGENIC FACTOR 1, SF1, PHOSPHOLIPID, PHOSPHATIDYL ETHANOLAMINE, PHOSPHATIDYL GLYCEROL, TRANSCRIPTION 
1yp0:A   (LEU345) to   (ALA459)  STRUCTURE OF THE STEROIDOGENIC FACTOR-1 LIGAND BINDING DOMAIN BOUND TO PHOSPHOLIPID AND A SHP PEPTIDE MOTIF  |   LIGAND DEPENDENT NUCLEAR RECEPTOR, STEROIDOGENIC FACTOR-1, NR5A1, HELICAL SANDWICH FOLD, LBD FOLD, TRANSCRIPTION 
3l03:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTETROL (ESTRA-1,3,5(10)-TRIENE-3,15 ALPHA, 16ALPHA,17BETA-TETROL)  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, ESTETROL, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR 
3l03:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND ESTETROL (ESTRA-1,3,5(10)-TRIENE-3,15 ALPHA, 16ALPHA,17BETA-TETROL)  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, ESTETROL, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR 
3l0e:A   (VAL347) to   (ASP458)  X-RAY CRYSTAL STRUCTURE OF A POTENT LIVER X RECEPTOR MODULATOR  |   HLXR-BETA, HUMAN LIVER X RECEPTOR-BETA, SULFONAMIDE MODULATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, ACTIVATOR, PHOSPHOPROTEIN 
1n4h:A   (ASP129) to   (THR233)  CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA  |   ALPHA-HELICAL SANDWICH, PROTEIN-PEPTIDE-LIGAND COMPLEX, HORMONE/GROWTH FACTOR COMPLEX 
3l1b:A   (SER362) to   (TRP473)  COMPLEX STRUCTURE OF FXR LIGAND-BINDING DOMAIN WITH A TETRAHYDROAZEPINOINDOLE COMPOUND  |   NUCLEAR RECEPTOR, FXR AGONIST, FXR LIGAND-BINDING DOMAIN, NUCLEUS, RECEPTOR, TRANSCRIPTION REGULATION, TRANSCRIPTION 
3ads:A   (ARG357) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH INDOMETHACIN  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3ads:B   (PRO359) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH INDOMETHACIN  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3adu:A   (GLU365) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH 5-METHOXY-INDOLE ACETATE  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3adv:A   (ARG357) to   (LYS474)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH SEROTONIN  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3adw:A   (MET364) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH 5-METHOXY-INDOLE ACETATE AND 15-OXO-EICOSATETRAENOIC ACID  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3adw:B   (PRO359) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH 5-METHOXY-INDOLE ACETATE AND 15-OXO-EICOSATETRAENOIC ACID  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3adx:A   (ARG357) to   (TYR473)  HUMAN PPARGAMMA LIGAND-BINDING DOMAIN IN COMPLEX WITH INDOMETHACIN AND NITRO-233  |   NUCLEAR RECEPTOR, LIGAND-DEPENDENT TRANSCRIPTION FACTOR, LIGAND- BINDING DOMAIN, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA- BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3l3z:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF DHT-BOUND ANDROGEN RECEPTOR IN COMPLEX WITH THE THIRD MOTIF OF STEROID RECEPTOR COACTIVATOR 3  |   ANDROGEN RECEPTOR, LIGAND BINDING DOMAIN, STEROID RECEPTOR COACTIVATOR 3, 5-ALPHA-DIHYDROTESTOSTERONE (DHT), PROSTATE CANCER, PROTEIN BINDING 
5did:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(2,3-DIFLUORO-4-HYDROXYPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1- OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5die:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR, 5S,7AS)-7A-METHYL-5-(2,3,5-TRIFLUORO-4-HYDROXYPHENYL)OCTAHYDRO-1H- INDEN-1-OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dig:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUOROMETHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S, 3AR,5S,7AS)-5-[4-HYDROXY-2-(TRIFLUOROMETHYL)PHENYL]-7A- METHYLOCTAHYDRO-1H-INDEN-1-OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
1yuc:B   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO PHOSPHOLIPID AND A FRAGMENT OF HUMAN SHP  |   LIVER RECEPTOR HOMOLOGUE 1; NUCLEAR RECEPTOR LIGAND BINDING DOMAIN; LRH-1; PHOSPHOLIPID; SHP; SMALL HETERODIMER PARTNER, TRANSCRIPTION REGULATION 
5dk9:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4, 4'-{2-[3-(PHENYLAMINO)PHENYL]BUT-1-ENE-1,1-DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dkg:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A T-BUTYL-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'- [2-(4-TERT-BUTYLPHENYL)PROP-1-ENE-1,1-DIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dkg:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A T-BUTYL-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'- [2-(4-TERT-BUTYLPHENYL)PROP-1-ENE-1,1-DIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dks:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-NAPHTHYLAMINO-SUBSTITUTED, ETHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'-{2-[3-(NAPHTHALEN-1-YLAMINO)PHENYL]BUT-1-ENE-1,1- DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dks:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-NAPHTHYLAMINO-SUBSTITUTED, ETHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'-{2-[3-(NAPHTHALEN-1-YLAMINO)PHENYL]BUT-1-ENE-1,1- DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dl4:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'-{2-[3-(PHENYLAMINO)PHENYL]PROP-1-ENE-1,1-DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dl4:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4'-{2-[3-(PHENYLAMINO)PHENYL]PROP-1-ENE-1,1-DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4ple:A   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO AN E. COLI PHOSPHOLIPID AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, PHOSPHOLIPID, TRANSCRIPTION 
4ple:C   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO AN E. COLI PHOSPHOLIPID AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, PHOSPHOLIPID, TRANSCRIPTION 
4ple:E   (ALA422) to   (HIS537)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO AN E. COLI PHOSPHOLIPID AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, PHOSPHOLIPID, TRANSCRIPTION 
4ple:G   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO AN E. COLI PHOSPHOLIPID AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, PHOSPHOLIPID, TRANSCRIPTION 
5dlr:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIARYL-ETHYLENE COMPOUND 4,4'-(2-PHENYLETHENE-1,1-DIYL) DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dlr:B   (GLY420) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIARYL-ETHYLENE COMPOUND 4,4'-(2-PHENYLETHENE-1,1-DIYL) DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dmc:A   (MET421) to   (HIS547)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A NITRILE-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 3,3-BIS(4- HYDROXYPHENYL)-2-PHENYLPROP-2-ENENITRILE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dmc:B   (VAL422) to   (HIS547)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A NITRILE-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 3,3-BIS(4- HYDROXYPHENYL)-2-PHENYLPROP-2-ENENITRILE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dmf:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED, METHYL TRIARYL-ETHYLENE DERIVATIVE 4,4'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}PROP-1-ENE-1,1- DIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4pp6:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RESVERATROL  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, NUCLEUS, PROTEIN BINDING 
4prg:A   (ARG357) to   (TYR473)  0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL  |   THIAZOLIDINONE, LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, ORPHAN RECEPTOR 
4prg:B   (PHE374) to   (TYR473)  0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL  |   THIAZOLIDINONE, LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, ORPHAN RECEPTOR 
4prg:C   (ARG357) to   (TYR473)  0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL  |   THIAZOLIDINONE, LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, ORPHAN RECEPTOR 
4ami:A   (ASN204) to   (PRO321)  TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND BIASED AGONIST BUCINDOLOL  |   MEMBRANE PROTEIN, 7TMR BETA1-ADRENOCEPTOR, STABILISING MUTATIONS, BIASED AGONIST 
5dp0:A   (GLU419) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 4, 4'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}ETHENE-1,1-DIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dp0:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 4, 4'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}ETHENE-1,1-DIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5drj:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3-METHYL 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4'-(3-METHYLTHIENE-2,5-DIYL)BIS(3-CHLOROPHENOL)  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5drj:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3-METHYL 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4'-(3-METHYLTHIENE-2,5-DIYL)BIS(3-CHLOROPHENOL)  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5drm:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4'- THIENE-2,5-DIYLBIS(3-CHLOROPHENOL)  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5drm:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4'- THIENE-2,5-DIYLBIS(3-CHLOROPHENOL)  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dsh:A   (LYS358) to   (TYR473)  HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1406 IN A COVALENT BONDED FORM  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
4pwl:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA-LBD AND THE S ENANTIOMER OF MBX-102 (METAGLIDASEN)  |   ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, ACTIVATOR, DNA- BINDING, NUCLEUS, OBESITY, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION X-RAY DIFFRACTION, TRANSCRIPTION FACTOR, RXR-ALPHA 
4pwl:B   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA-LBD AND THE S ENANTIOMER OF MBX-102 (METAGLIDASEN)  |   ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, ACTIVATOR, DNA- BINDING, NUCLEUS, OBESITY, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION X-RAY DIFFRACTION, TRANSCRIPTION FACTOR, RXR-ALPHA 
1zdt:A   (GLY341) to   (ALA458)  THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1  |   STEROIDOGENIC FACTOR-1, NUCLEAR RECEPTOR, PHOLPHOLIPID, PHOSPHATIDYLETHANOLAMINE, TRANSCRIPTION 
5dtv:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIMETHYL-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
3an3:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MO3S  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3an3:B   (PRO359) to   (ILE472)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MO3S  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3an4:A   (ARG357) to   (LYS474)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MO4R  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3an4:B   (LYS358) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMA SELECTIVE AGONIST MO4R  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
5due:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PARA-HYDROXYL-SUBSTITUTED, SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG 4-HYDROXYPHENYL (1S,2S,4S,5S,6R, 7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7-THIABICYCLO[2.2.1]HEPTANE-2- SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5due:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PARA-HYDROXYL-SUBSTITUTED, SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG 4-HYDROXYPHENYL (1S,2S,4S,5S,6R, 7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7-THIABICYCLO[2.2.1]HEPTANE-2- SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
1zgy:A   (ARG357) to   (TYR473)  STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP  |   PROTEIN-PEPTIDE COMPLEX, TRANSCRIPTION 
5duh:A   (VAL418) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-3 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-3-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5duh:B   (MET421) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-3 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-3-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dv3:A   (LYS358) to   (LYS474)  HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1405 IN A COVALENT BONDED FORM  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
5dv6:A   (LYS358) to   (TYR473)  HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1404 IN A COVALENT BONDED FORM  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
5dv8:A   (MET364) to   (TYR473)  HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1451 IN A COVALENT BONDED FORM  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
5dvc:A   (LYS358) to   (TYR473)  HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1453 IN A COVALENT BONDED FORM  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
5dwe:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-CHLORO-SUBSTITUTED TRIARYL-IMINE ANALOG 4,4'-[(2- CHLOROPHENYL)CARBONIMIDOYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dwe:B   (GLY420) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-CHLORO-SUBSTITUTED TRIARYL-IMINE ANALOG 4,4'-[(2- CHLOROPHENYL)CARBONIMIDOYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dwj:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 4-FLUORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(4-FLUOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dwj:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 4-FLUORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(4-FLUOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dwl:A   (LYS358) to   (TYR473)  HUMAN PPARGAMMA LIGAND BINDING DMAIN IN COMPLEX WITH SR1664  |   PPARGAMMA, ANTAGONIST, TRANSCRIPTION-TRANSFERASE COMPLEX 
3lmp:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR  |   THREE-LAYERED ALPHA-HELICAL SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
5dxg:A   (MET421) to   (ARG548)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P5  |   ESTROGEN RECEPTOR, HORMONE, STAPLED PEPTIDE, PEPTIDE MIMETIC, BREAST CANCER, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dxg:B   (MET421) to   (ARG548)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P5  |   ESTROGEN RECEPTOR, HORMONE, STAPLED PEPTIDE, PEPTIDE MIMETIC, BREAST CANCER, HORMONE RECEPTOR-PEPTIDE COMPLEX 
1zky:A   (MET421) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-3M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
1zky:B   (MET421) to   (ALA546)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH OBCP-3M AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
5dxb:A   (VAL422) to   (ARG548)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P1 AND ESTRADIOL  |   ESTROGEN RECEPTOR ALPHA, SOMATIC MUTATAION, STAPLED PEPTIDE, PEPTIDE MIMETIC, HORMONE RECEPTOR, BREAST CANCER, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dxb:B   (MET421) to   (ARG548)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P1 AND ESTRADIOL  |   ESTROGEN RECEPTOR ALPHA, SOMATIC MUTATAION, STAPLED PEPTIDE, PEPTIDE MIMETIC, HORMONE RECEPTOR, BREAST CANCER, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dxe:A   (MET421) to   (ASP545)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P4 AND ESTRADIOL  |   ESTROGEN RECEPTOR ALPHA, STAPLED PEPTIDE, PEPTIDE MIMETIC, BREAST CANCER, HORMONE, SOMATIC MUTATION, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dxe:B   (MET421) to   (ARG548)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P4 AND ESTRADIOL  |   ESTROGEN RECEPTOR ALPHA, STAPLED PEPTIDE, PEPTIDE MIMETIC, BREAST CANCER, HORMONE, SOMATIC MUTATION, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dxk:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(9S)-BICYCLO[3.3.1]NON-9- YLMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxk:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(9S)-BICYCLO[3.3.1]NON-9- YLMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxm:A   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 3-[(E)-(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENE(4-HYDROXYPHENYL)METHYL]PHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxp:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4-[(E)-(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENE(PHENYL)METHYL]PHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxq:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENEMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxq:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENEMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dy8:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3- ETHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz0:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4-METHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz0:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4-METHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz1:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4-ETHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz1:B   (GLY420) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4-ETHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz3:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(FLUOROMETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dzh:A   (VAL422) to   (VAL533)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dzh:B   (GLU419) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dzi:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e15:A   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e15:B   (MET421) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4q50:A   (VAL422) to   (ASP545)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
4q50:B   (MET421) to   (ASP545)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
4q50:D   (VAL422) to   (ASP545)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
4q50:E   (MET421) to   (ASP545)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
4q50:H   (MET421) to   (LEU544)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
5e19:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE METHYL {4-[BIS(4-HYDROXYPHENYL) METHYLIDENE]CYCLOHEXYL}ACETATE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e1c:A   (GLY420) to   (LEU549)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE DIMETHYL {(1S)-3-[BIS(4- HYDROXYPHENYL)METHYLIDENE]CYCLOHEXYL}PROPANEDIOATE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e1c:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE DIMETHYL {(1S)-3-[BIS(4- HYDROXYPHENYL)METHYLIDENE]CYCLOHEXYL}PROPANEDIOATE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
3aun:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH YR335 AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205  |   BINDING SITES, BIPHENYL COMPOUNDS, PROTEIN BINDING, TERTIARY, RATS, RECEPTORS, CALCITRIOL, VITAMIN D, TRANSCRIPTION 
3auq:A   (SER306) to   (PHE422)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH YNE-DIENE TYPE ANALOG OF ACTIVE 14-EPI-2ALPHA- METHYL-19-NORVITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
4qe6:A   (SER358) to   (ILE468)  FXR WITH CDCA AND NCOA-2 PEPTIDE  |   RECEPTOR, BILE ACID RECEPTOR DNA, TRANSCRIPTION 
4qe8:A   (ASP359) to   (TRP469)  FXR WITH DM175 AND NCOA-2 PEPTIDE  |   RECEPTOR, BILE ACID RECEPTOR DNA, TRANSCRIPTION 
3az1:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
3az3:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
3b0q:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH MCC555  |   NUCLEAR RECEPTOR, TRANSCRIPTION 
3b0q:B   (LYS358) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH MCC555  |   NUCLEAR RECEPTOR, TRANSCRIPTION 
3b0t:A   (SER306) to   (GLY423)  HUMAN VDR LIGAND BINDING DOMAIN IN COMPLEX WITH MAXACALCITOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION, GENE REGULATION 
3b1m:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR CERCO-A  |   TRANSCRIPTION 
3m7r:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF VDR H305Q MUTANT  |   LIGAND BINDING DOMAIN, TRANSCRIPTION, STRUCTURAL GENOMICS, SPINE, STRUCTURAL PROTEOMICS IN EUROPE 
3b3k:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA AND THE FULL AGONIST LT175  |   BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRNDED BETA-SHEET, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHORYLATION, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
5ehj:A   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4AR,8AR)-OCTAHYDRONAPHTHALEN- 2(1H)-YLIDENEMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5ehj:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-[(4AR,8AR)-OCTAHYDRONAPHTHALEN- 2(1H)-YLIDENEMETHANEDIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
2acl:B   (VAL331) to   (TRP441)  LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987  |   NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD 
2acl:D   (VAL331) to   (TRP441)  LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987  |   NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD 
2acl:F   (VAL331) to   (TRP441)  LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987  |   NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD 
4qjr:A   (SER342) to   (ALA458)  CRYSTAL STRUCTURE OF HUMAN NUCLEAR RECEPTOR SF-1 (NR5A1) BOUND TO ITS HORMONE PIP3 AT 2.4 A RESOLUTION  |   NUCLEAR HORMONE RECEPTOR, NR5A1, SF-1 LIGAND BINDINGNUCLEAR DOMAIN, REGULATORY LIGANDS, TRANSCRIPTION, TRANSCRIPTION REGULATION, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, PARTNERSHIP FOR STEM CELL BIOLOGY, PIP3, PIP2, NUCLEUS, NUCLEAR PHOSPHATIDYLINOSITOL PHOSPHATES, TRANSCRIPTION FACTOR-HORMONE COMPLEX 
4qk4:A   (SER342) to   (ALA458)  CRYSTAL STRUCTURE OF HUMAN NUCLEAR RECEPTOR SF-1 (NR5A1) BOUND TO PIP2 AT 2.8 A RESOLUTION  |   NUCLEAR HORMONE RECEPTOR, NR5A1, SF-1 LIGAND BINDING DOMAIN, REGULATORY LIGANDS, TRANSCRIPTION, TRANSCRIPTION REGULATION, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, PARTNERSHIP FOR STEM CELL BIOLOGY, PIP3, PIP2, NUCLEUS, NUCLEAR PHOSPHATIDYLINOSITOL PHOSPHATES, TRANSCRIPTION FACTOR-HORMONE COMPLEX 
4bcr:A   (LYS349) to   (TYR464)  STRUCTURE OF PPARALPHA IN COMPLEX WITH WY14643  |   TRANSCRIPTION, NUCLEAR RECEPTOR, PPAR, FIBRATE 
4bcr:B   (LYS349) to   (TYR464)  STRUCTURE OF PPARALPHA IN COMPLEX WITH WY14643  |   TRANSCRIPTION, NUCLEAR RECEPTOR, PPAR, FIBRATE 
3bej:A   (ASP359) to   (TRP469)  STRUCTURE OF HUMAN FXR IN COMPLEX WITH MFA-1 AND CO- ACTIVATOR PEPTIDE  |   FXR, BAR, NR1H4, BILE ACID RECEPTOR, NHR, NUCLEAR RECEPTOR, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, REPRESSOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSFERASE COMPLEX, TRANSCRIPTION REGULATOR 
5f9b:A   (ARG357) to   (TYR473)  X-RAY CRYSTAL STRUCTURE OF PPARGAMMA IN THE COMPLEX WITH CAULOPHYLLOGENIN  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, BUNDLE OF ALPHA- HELICES, TRANSCRIPTION 
4r06:A   (GLU365) to   (TYR473)  CRYSTAL STRUCTURE OF SR2067 BOUND TO PPARGAMMA  |   NUCLEAR RECEPTOR, LIGAND BINDING PROTEIN, TRANSCRIPTION 
4r2u:D   (GLU365) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA IN COMPLEX WITH SR1664  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
4r6s:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMMA IN COMPLEX WITH SR1663  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
4r6s:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMMA IN COMPLEX WITH SR1663  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
4rak:B   (GLN346) to   (TRP457)  CRYSTAL STRUCTURE OF NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2 (LXRB) COMPLEXED WITH PARTIAL AGONIST  |   NHR, NR1H2, LXR-B, LXRB, UNR, NER-I, RIP15, NER, LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, RXR, TRANSCRIPTION-AGONIST COMPLEX 
3cds:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPAR-GAMMA AND THE AGONIST LT248 (CLOFIBRIC ACID ANALOGUE)  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA- SHEET, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3cjw:A   (MET289) to   (LEU381)  CRYSTAL STRUCTURE OF THE HUMAN COUP-TFII LIGAND BINDING DOMAIN  |   COUP-TFII, NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, ORPHAN RECEPTOR, THREE-LAYERED HELICAL SANDWICH, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3noa:A   (PRO359) to   (TYR473)  CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEX WITH A POTENCY IMPROVED AGONIST  |   HYPOGLYCEMIC AGENTS, MODELS, MOLECULAR, PPAR ALPHA, PPAR GAMMA, PROTEIN ISOFORMS, QUINOLINES, STRUCTURE-ACTIVITY RELATIONSHIP, THIAZOLIDINEDIONES, TRANSCRIPTION 
5fqp:A   (MET421) to   (LEU544)  SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: TETRAHYDROISOQUINOLINE PHENOLS 1.  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, THIQ, NUCLEAR HORMONE RECEPTOR 
5fqs:A   (MET421) to   (LEU544)  SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: TETRAHYDROISOQUINOLINE PHENOLS 3.  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, THIQ, NUCLEAR HORMONE RECEPTOR 
5fqt:A   (MET421) to   (LEU544)  SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: TETRAHYDROISOQUINOLINE PHENOLS 4.  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, THIQ, NUCLEAR HORMONE RECEPTOR 
3cs4:A   (SER306) to   (GLY423)  STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR  |   VDR, SUPERAGONIST, DISEASE MUTATION, DNA-BINDING, METAL- BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, GENE REGULATION 
3cs8:A   (MET364) to   (TYR473)  STRUCTURAL AND BIOCHEMICAL BASIS FOR THE BINDING SELECTIVITY OF PPARG TO PGC-1A  |   COACTIVATOR, NUCLEAR RECEPTOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL- BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, RNA-BINDING, NUCLEAR PROTEIN 
4ci4:A   (LYS349) to   (TYR464)  STRUCTURAL BASIS FOR GL479 A DUAL PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR ALPHA AGONIST  |   TRANSFERASE, DUAL AGONIST, PPAR, NUCLEAR RECEPTOR, GL479 
4ci5:A   (MET364) to   (TYR473)  STRUCTURAL BASIS FOR GL479 A DUAL PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR GAMMA AGONIST  |   NUCLEAR PROTEIN, DUAL AGONIST, NUCLEAR RECEPTOR 
3o1e:A   (THR334) to   (LEU440)  STRUCTURE-FUNCTION OF GEMINI DERIVATIVES WITH TWO DIFFERENT SIDE CHAINS AT C-20, GEMINI-0072 AND GEMINI-0097.  |   TRANSCRIPTION FACTOR, VITAMIN D, NUCLEUS, TRANSCRIPTION-TRANSCRIPTION ACTIVATOR COMPLEX 
3cwd:A   (ARG357) to   (TYR473)  MOLECULAR RECOGNITION OF NITRO-FATTY ACIDS BY PPAR GAMMA  |   PPAR GAMMA, NUCLEAR RECEPTOR, SRC1-2 MOTIF, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
4rwv:A   (ALA422) to   (ALA538)  CRYSTAL STRUCTURE OF PIP3 BOUND HUMAN NUCLEAR RECEPTOR LRH-1 (LIVER RECEPTOR HOMOLOG 1, NR5A2) IN COMPLEX WITH A CO-REGULATOR DAX-1 (NR0B1) PEPTIDE AT 1.86 A RESOLUTION  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, PF00104 FAMILY, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, PARTNERSHIP FOR STEM CELL BIOLOGY, TRANSCRIPTION 
4rzg:B   (TRP151) to   (LEU265)  CRYSTAL STRUCTURE ANALYSIS OF THE DNPA-BOUNDED NUR77 LIGAND BINDING DOMAIN  |   NUR77-LBD AND DNPA COMPLEX, TRANSCRIPTION 
4s0t:A   (PRO322) to   (PHE429)  STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1  |   NUCLEAR RECEPTOR, MULTIPLE BINDING MODES, XENOBIOTIC, PROMISCUOUS, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION 
4s15:A   (ASP398) to   (THR512)  CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORALPHA LIGAND- BINDING DOMAIN IN COMPLEX WITH 4ALPHA-CABOXYL, 4BETA-METHYL- ZYMOSTEROL (4ACD8)  |   TRANSCRIPTION FACTOR, TRANSCRIPTION 
4s15:B   (ASP398) to   (ARG500)  CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORALPHA LIGAND- BINDING DOMAIN IN COMPLEX WITH 4ALPHA-CABOXYL, 4BETA-METHYL- ZYMOSTEROL (4ACD8)  |   TRANSCRIPTION FACTOR, TRANSCRIPTION 
3d57:B   (VAL348) to   (GLU460)  TR VARIANT D355R  |   THYROID HORMONE RECEPTOR, LIGAND BINDING DOMAIN, D355R MUTANT, HOMODIMER, ALTERNATIVE SPLICING, DEAFNESS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, HORMONE, TRANSCRIPTION RECEPTOR 
3d5f:A   (LYS358) to   (LYS474)  CRYSTAL STRUCTURE OF PPAR-DELTA COMPLEX  |   NUCLEAR RECEPTOR, ACTIVATOR, ALTERNATIVE SPLICING, DNA- BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3d5f:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPAR-DELTA COMPLEX  |   NUCLEAR RECEPTOR, ACTIVATOR, ALTERNATIVE SPLICING, DNA- BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3dct:A   (ASP359) to   (TRP469)  FXR WITH SRC1 AND GW4064  |   FXR, NUCLEAR RECEPTOR, GW4064, ALPHA-HELICAL SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, REPRESSOR, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, PHOSPHOPROTEIN, POLYMORPHISM, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION, TRANSCRIPTION/TRANSCRIPTION ACTIVATOR COMPLEX 
3ogt:A   (SER306) to   (GLY423)  DESIGN, CHEMICAL SYNTHESIS, FUNCTIONAL CHARACTERIZATION AND CRYSTAL STRUCTURE OF THE SIDECHAIN ANALOGUE OF 1,25-DIHYDROXYVITAMIN D3.  |   TRANSCRIPTION FACTOR, VITAMIN D, NUCLEUS, TRANSCRIPTION 
4tv1:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH PROPYLPARABEN  |   NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, ENDOCRINE DISRUPTOR, ENVIRONMENTAL COMPOUND, HORMONE RECEPTOR 
3oki:C   (SER362) to   (TRP458)  CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4- CHLOROPHENYL)-1H-BENZIMIDAZOL-1-YL]-N,2-DICYCLOHEXYLETHANAMIDE  |   NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR 
3omk:A   (SER362) to   (SER457)  CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYL-N-(2- METHYLPHENYL)ETHANAMIDE  |   NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR 
3omm:C   (SER362) to   (TRP458)  CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)-3-FLUOROBENZOIC ACID  |   NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR 
5gt4:A   (SER306) to   (PHE422)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH (1R,2S,3R,5Z,7E,14BETA,17ALPHA)-2-CYANOPROPOXY- 9,10-SECOCHOLESTA-5,7,10-TRIENE-1,3,25-TRIOL  |   NUCLEAR HORMONE RECEPTOR FULL AGONIST LIGAND COMPLEX, TRANSCRIPTION 
3oof:A   (ASP363) to   (TRP458)  CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)BENZOIC ACID  |   NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR 
3oof:C   (SER362) to   (SER457)  CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)BENZOIC ACID  |   NUCLEAR RECEPTOR, CHOLESTEROL, BILE ACID, DNA-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, LIGAND BINDING DOMAIN TRANSCRIPTION REGULATION, COACTIVATOR, FXR ALTERNATIVE SPLICING, HORMONE RECEPTOR 
3os8:A   (VAL418) to   (LEU544)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os8:B   (VAL418) to   (LEU544)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os8:C   (VAL422) to   (ALA546)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os8:D   (VAL422) to   (ALA546)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3osi:A   (GLU365) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TETRACHLORO-BISPHENOL A (TCBPA)  |   TRANSCRIPTION, LIGAND BINDING PROTEIN 
3os9:A   (VAL422) to   (ASP545)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os9:B   (VAL422) to   (ASP545)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os9:C   (VAL422) to   (ASP545)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3os9:D   (VAL422) to   (LEU544)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3osa:C   (MET421) to   (ALA546)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
3osa:D   (MET421) to   (ALA546)  ESTROGEN RECEPTOR  |   ESTROGEN RECEPTOR COMPLEX, SIGNALING PROTEIN 
5hbh:B   (ASP187) to   (MET257)  CDK8-CYCC IN COMPLEX WITH 5-{5-CHLORO-4-[1-(2-METHOXY-ETHYL)-1,8- DIAZA-SPIRO[4.5]DEC-8-YL]-PYRIDIN-3-YL}-1-METHYL-1,3-DIHYDRO- BENZO[C]ISOTHIAZOLE 2,2-DIOXIDE  |   CDK8 KINASE / CYCLIN C, TRANSFERASE 
3osw:A   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TETRABROMO-BISPHENOL A (TBBPA)  |   TRANSCRIPTION, LIGAND BINDING PROTEIN 
3oz0:A   (LYS358) to   (TYR473)  PPAR DELTA IN COMPLEX WITH AZPPARD02  |   TRANSCRIPTION FACTOR, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
3dy6:A   (LYS358) to   (TYR473)  PPARDELTA COMPLEXED WITH AN ANTHRANILIC ACID PARTIAL AGONIST  |   PPAR, NULEAR RECEPTOR, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3dy6:B   (LYS358) to   (TYR473)  PPARDELTA COMPLEXED WITH AN ANTHRANILIC ACID PARTIAL AGONIST  |   PPAR, NULEAR RECEPTOR, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
3p0u:B   (VAL487) to   (LEU580)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN TESTICULAR RECEPTOR 4  |   LIGAND BINDING DOMAIN, ORPHAN NUCLEAR RECEPTOR, TESTICULAR RECEPTOR 4, SIGNALING PROTEIN 
4dk8:C   (GLN346) to   (TRP457)  CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST 5  |   LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION- PEPTIDE-AGONIST COMPLEX 
5hjs:B   (VAL169) to   (TRP279)  IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE  |   AGONIST, ALZHEIMER'S, SIGNALING PROTEIN 
5hk7:C   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL PORE, 2.95 ANGSTROM RESOLUTION  |   BACTERIAL SODIUM CHANNEL PORE, TRANSPORT PROTEIN 
5hk7:D   (ILE150) to   (ARG283)  BACTERIAL SODIUM CHANNEL PORE, 2.95 ANGSTROM RESOLUTION  |   BACTERIAL SODIUM CHANNEL PORE, TRANSPORT PROTEIN 
4dma:A   (VAL422) to   (LEU549)  CRYSTAL STRUCTURE OF ERA LBD IN COMPLEX WITH RU100132  |   TRANSCRIPTION, NUCLEAR RECEPTOR, ER, ESTROGEN RECEPTOR, ALPHA HELICAL SANDWICH, TRANSCRIPTION FACTOR, ESTRADIOL, TRANSCRIPTION-PROTEIN BINDING-AGONIST COMPLEX 
4dor:A   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, IN ITS APO STATE BOUND TO A FRAGMENT OF HUMAN SHP BOX1  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PHOSPHOLIPIDS, NR5A, DIABETES, PHOSPHATIDYLCHOLINE, TRANSCRIPTION 
4dor:B   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, IN ITS APO STATE BOUND TO A FRAGMENT OF HUMAN SHP BOX1  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PHOSPHOLIPIDS, NR5A, DIABETES, PHOSPHATIDYLCHOLINE, TRANSCRIPTION 
4dos:A   (ALA422) to   (ALA538)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO DLPC AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PHOSPHOLIPIDS, NR5A, DIABETES, PHOSPHATIDYLCHOLINE, DLPC, TRANSCRIPTION 
3p8x:A   (SER306) to   (PHE422)  SYNTHESIS, STRUCTURE, AND BIOLOGICAL ACTIVITY OF DES-SIDE CHAIN ANALOGUES OF 1ALPHA,25-DIHYDROXYVITAMIN D3 WITH SUBSTITUENTS AT C-18  |   HELICES SANDWICH, TRANSCRIPTION REGULATION, VITAMIN D, TRANSCRIPTION REGULATOR 
4dqm:A   (LEU308) to   (LEU414)  REVEALING A MARINE NATURAL PRODUCT AS A NOVEL AGONIST FOR RETINOIC ACID RECEPTORS WITH A UNIQUE BINDING MODE AND ANTITUMOR ACTIVITY  |   NUCLEAR RECEPTOR TRANSCRIPTION FACTOR, LIGAND BINDING DOMAIN, TRANSCRIPTION REGULATION, NUCLEUS, TRANSCRIPTION-TRANSFERASE COMPLEX 
4dqm:C   (THR306) to   (LEU414)  REVEALING A MARINE NATURAL PRODUCT AS A NOVEL AGONIST FOR RETINOIC ACID RECEPTORS WITH A UNIQUE BINDING MODE AND ANTITUMOR ACTIVITY  |   NUCLEAR RECEPTOR TRANSCRIPTION FACTOR, LIGAND BINDING DOMAIN, TRANSCRIPTION REGULATION, NUCLEUS, TRANSCRIPTION-TRANSFERASE COMPLEX 
3pba:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH MONOSULFATE TETRABROMO-BISPHENOL A (MONOTBBPA)  |   TRANSCRIPTION, LIGAND BINDING PROTEIN 
3pba:B   (LYS358) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH MONOSULFATE TETRABROMO-BISPHENOL A (MONOTBBPA)  |   TRANSCRIPTION, LIGAND BINDING PROTEIN 
5hyr:B   (MET421) to   (ASP545)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-SP2 AND ESTRADIOL  |   BREAST CANCER, ESTROGEN RECEPTOR, SYNTHETIC PEPTIDE, STAPLED PEPTIDE, ENDOCRINE, HORMONE, GENE REGULATION 
5hzc:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX PPARGAMMA/AL26-29  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, DIABETES, BUNDLE OF ALPHA- HELICES, TRANSCRIPTION 
3plz:A   (ALA422) to   (ALA538)  HUMAN LRH1 LBD BOUND TO GR470  |   ALPHA HELICAL SANDWHICH, NUCLEAR RECEPTOR, FAMILY FIVE, TRANSCRIPTION FACTOR, CO-ACTIVATOR, TRANSCRIPTION-RECEPTOR-AGONIST COMPLEX 
3po9:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH TRIPROPYLTIN  |   TRANSCRIPTION, LIGAND BINDING DOMAIN 
4e4k:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA WITH THE LIGAND JO21  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION FACTOR, TRANSCRIPTION 
4e4k:B   (PHE360) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA WITH THE LIGAND JO21  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION FACTOR, TRANSCRIPTION 
4e4q:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA WITH THE LIGAND FS214  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION FACTOR, TRANSCRIPTION 
3prg:A   (ARG357) to   (LYS474)  LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR  |   THIAZOLIDINEDIONE, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ADIPOCYTE DIFFERENTIATION 
4em9:A   (MET364) to   (TYR473)  HUMAN PPAR GAMMA IN COMPLEX WITH NONANOIC ACIDS  |   NUCLEAR RECEPTOR, RETINOIC ACID RECEPTOR, NUCLEUS, TRANSCRIPTION 
5iwn:B   (ALA151) to   (SER285)  BACTERIAL SODIUM CHANNEL PORE DOMAIN, HIGH BROMIDE  |   BACTERIAL SODIUM CHANNEL, LOW BR, TRANSPORT PROTEIN 
5iwn:C   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL PORE DOMAIN, HIGH BROMIDE  |   BACTERIAL SODIUM CHANNEL, LOW BR, TRANSPORT PROTEIN 
5iwo:A   (ALA151) to   (GLY286)  BACTERIAL SODIUM CHANNEL PORE DOMAIN, LOW BROMIDE  |   BACTERIAL SODIUM CHANNEL, HIGH BR, TRANSPORT PROTEIN 
3q95:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH GRIP PEPTIDE AND ESTRIOL  |   TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR 
3q97:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH GRIP PEPTIDE AND TWO ISOMERS OF ETHOXY TRIPHENYLETHYLENE  |   TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR 
3q97:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH GRIP PEPTIDE AND TWO ISOMERS OF ETHOXY TRIPHENYLETHYLENE  |   TRANSCRIPTIONAL REGULATOR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATOR 
4f9m:A   (PHE360) to   (TYR473)  CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR  |   THREE-LAYERED ALPHA-HELICAL SANDWICH, TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR COMPLEX 
3qt0:A   (MET364) to   (TYR473)  REVEALING A STEROID RECEPTOR LIGAND AS A UNIQUE PPARGAMMA AGONIST  |   PPAR GAMMA LBD DOMAIN, TRANSCRIPTION 
4fgy:A   (MET392) to   (TYR501)  IDENTIFICATION OF A UNIQUE PPAR LIGAND WITH AN UNEXPECTED BINDING MODE AND ANTIBETIC ACTIVITY  |   PPAR LBD, NUCLEAR RECEPTOR FOLD, LIGAND BINDING, GENE TRANSCRIPTION, TRANSCRIPTION-TRANSFERASE-ANTIBIOTIC COMPLEX 
4fhh:A   (THR334) to   (LEU440)  DEVELOPMENT OF SYNTHETICALLY ACCESSIBLE NON-SECOSTEROIDAL HYBRID MOLECULES COMBINING VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITION  |   LIGAND BINDING DOMAIN, APHA HELICAL SANDWICH, ALPHA HELICAL SANDWICH, TRANSCRIPTION FACTOR, ADN COREGULATORS, PHOSPHORYLATION AND HDAC INHIBITOR, NUCLEUS, TRANSCRIPTION-PROTEIN BINDING-INHIBITOR COMPLEX 
3r29:B   (VAL354) to   (MET454)  CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING DOMAIN, TRANSCRIPTION 
3r8a:B   (LYS358) to   (LYS474)  X-RAY CRYSTAL STRUCTURE OF THE NUCLEAR HORMONE RECEPTOR PPAR-GAMMA IN A COMPLEX WITH A COMPOUND WITH DUAL PPAR GAMMA AGONISM AND ANGIOTENSIN II TYPE I RECEPTOR ANTAGONISM ACTIVITY  |   NUCLEAR HORMONE ACTIVATOR, ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST, LIGAND BOUND STRUCTURE, DIABETES MELLITUS, METABOLIC SYNDROME, OBESITY, NUCLEAR PROTEIN 
3r8i:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA WITH AN ACHIRAL UREIDOFIBRATE DERIVATIVE (RT86)  |   PROTEIN-DNA COMPLEX, BUNDLE OF ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, TRANSCRIPTION, ACTIVATOR, DIABETES MELLITUS, OBESITY, TRANSCRIPTION REGULATION, DNA BINDING, PHOSPHORYLATION, NUCLEUS 
4g1d:A   (THR334) to   (LEU440)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   TRANSCRIPTION REGULATION, VDR, VITAMIN D, ALPHA HELICAL SANDWICH, TRANSCRIPTION, LIGAND, ADN, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION- TRANSCRIPTION INHIBITOR COMPLEX 
4g1y:A   (THR334) to   (THR441)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   VDR, TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, LIGAND, DNA, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION- TRANSCRIPTION INHIBITOR COMPLEX 
4g1z:A   (THR334) to   (PRO434)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   VDR, NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, ALPHA HELICAL SANDWICH, LIGAND, DNA, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION- TRANSCRIPTION INHIBITOR COMPLEX 
4g2i:A   (SER306) to   (GLY423)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   VDR, TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, LIGAND, DNA, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION- TRANSCRIPTION INHIBITOR COMPLEX 
5kce:B   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL, 2-CHLOROBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, SIGNALING PROTEIN, TRANSCRIPTION 
5kcf:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-METHOXYBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcf:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-METHOXYBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kct:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-CHLOROBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcu:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, ALPHA-NAPHTHYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcu:B   (MET421) to   (LEU544)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, ALPHA-NAPHTHYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcw:A   (GLY420) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcw:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kd9:A   (VAL422) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL 4-CHLOROBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5lga:A   (THR334) to   (LEU440)  STRUCTURAL ANALYSIS AND BIOLOGICAL ACTIVITIES OF BXL0124, A GEMINI ANALOG OF VITAMIN D  |   VITAMIN D NUCLEAR RECEPTOR, AGONIST, GEMINI, TRANSCRIPTION 
5syz:A   (ALA422) to   (ALA538)  HUMAN LIVER RECEPTOR HOMOLOGUE-1 (LRH-1) BOUND TO A RJW100 STEREOISOMER AND A FRAGMENT OF TIF-2  |   NUCLEAR RECEPTOR, AGONIST, COACTIVATOR, NUCLEAR PROTEIN 
5t3t:F   (SER182) to   (VAL265)  EBOLA VIRUS VP30 CTD BOUND TO NUCLEOPROTEIN  |   TRANSCRIPTION, REPLICATION, REGULATOR, CO-FACTOR, VIRAL PROTEIN 
5t3t:G   (SER182) to   (VAL265)  EBOLA VIRUS VP30 CTD BOUND TO NUCLEOPROTEIN  |   TRANSCRIPTION, REPLICATION, REGULATOR, CO-FACTOR, VIRAL PROTEIN 
5t3t:J   (SER182) to   (VAL265)  EBOLA VIRUS VP30 CTD BOUND TO NUCLEOPROTEIN  |   TRANSCRIPTION, REPLICATION, REGULATOR, CO-FACTOR, VIRAL PROTEIN 
2ocf:A   (VAL422) to   (ARG548)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH ESTRADIOL AND THE E2#23 FN3 MONOBODY  |   ESTROGEN RECEPTOR, LBD, MONOBODY, ESTRADIOL, HORMONE-GROWTH FACTOR COMPLEX 
3s27:B   (LEU203) to   (VAL275)  THE CRYSTAL STRUCTURE OF SUCROSE SYNTHASE-1 FROM ARABIDOPSIS THALIANA AND ITS FUNCTIONAL IMPLICATIONS.  |   GLYCOSYLTRANSFERASE, SUCROSE METABOLISM, SUGAR ACCEPTOR COMPLEX, ROSSMANN FOLD, GT-B FOLD, UDP, FRUCTOSE, CYTOSOL, TRANSFERASE 
4hee:X   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA IN COMPLEX WITH COMPOUND 13  |   PPARGAMMA, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX 
3s29:B   (ASN202) to   (VAL275)  THE CRYSTAL STRUCTURE OF SUCROSE SYNTHASE-1 FROM ARABIDOPSIS THALIANA AND ITS FUNCTIONAL IMPLICATIONS.  |   GLYCOSYLTRANSFERASE, SUCROSE METABOLISM, SUGAR ACCEPTOR COMPLEX, ROSSMANN FOLD, GT-B FOLD, UDP, FRUCTOSE, CYTOSOL, TRANSFERASE 
2pin:B   (VAL348) to   (GLU460)  THYROID RECEPTOR BETA IN COMPLEX WITH INHIBITOR  |   THYROID RECEPTOR BETA, NUCLEAR RECEPTORS, INHIBITORS, PROTEIN-PROTEIN INTERACTIONS, COREGULATOR BINDING, AF-2 POCKET, AROMATIC-BETA-AMINO KETONES, STRUCTURE-BASED DRUG DESIGN, SURFACE INTERACTING DRUGS, HORMONE RECEPTOR 
2pip:L   (MET780) to   (SER888)  ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE  |   ANDROGEN RECEPTOR, COACTIVATORS, AF-2 POCKET, INHIBITORS, HORMONE RECEPTOR 
2pit:A   (MET780) to   (SER888)  ANDROGEN RECEPTOR LBD WITH SMALL MOLECULE  |   ANDROGEN RECEPTOR COACTIVATOR BINDING INHIBITORS AF-2, HORMONE RECEPTOR 
3fej:A   (ARG357) to   (TYR473)  DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED DUAL PPARA/G AGONISTS  |   NUCLEAR RECPETOR,TRANSCRIPTION FACTOR, DIABETES, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
4xhd:A   (PRO322) to   (LEU428)  STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH COMPOUND-1  |   PREGNANE X RECEPTOR, PXR, LIGAND BINDING DOMAIN, STEROID RECEPTOR COACTIVATOR-1; CCR1, CHEMOKINE RECEPTOR-1; ADNECTIN NR, NUCLEAR RECEPTOR; AF, ACTIVATION FUNCTION; CYP, CYTOCHROME P450; MDR1, MULTI-DRUG RESISTANCE GENE-1., TRANSCRIPTION 
2prg:A   (ARG357) to   (TYR473)  LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA  |   COMPLEX (THIAZOLIDINEDIONE/RECEPTOR), LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, APO, TRANSCRIPTION FACTOR, ORPHAN RECEPTOR 
2prg:B   (ARG357) to   (TYR473)  LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA  |   COMPLEX (THIAZOLIDINEDIONE/RECEPTOR), LIGAND-BINDING DOMAIN, NUCLEAR RECEPTOR, APO, TRANSCRIPTION FACTOR, ORPHAN RECEPTOR 
1osh:A   (ASP363) to   (ILE472)  A CHEMICAL, GENETIC, AND STRUCTURAL ANALYSIS OF THE NUCLEAR BILE ACID RECEPTOR FXR  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, TRANSCRIPTION 
2q5p:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST MRL24  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
2q5p:B   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF PPARGAMMA BOUND TO PARTIAL AGONIST MRL24  |   PROTEIN-LIGAND COMPLEX, LIGAND BINDING PROTEIN 
4xuh:A   (GLU365) to   (TYR473)  PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH SULINDAC SULFIDE  |   NUCLEAR RECEPTOR, PPARGAMMA, SULINDAC SULFIDE, NSAIDS, TRANSLATION 
4ite:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 1ALPHA,25-DIHYDROXY-2ALPHA-[2-(2H-TETRAZOL-2- YL)ETHYL]VITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
1pqc:A   (GLN346) to   (TRP457)  HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317  |   LXRB+T0901317, TRANSCRIPTION REGULATION 
3gyt:A   (ARG630) to   (PHE749)  NUCLEAR RECEPTOR DAF-12 FROM PARASITIC NEMATODE STRONGYLOIDES STERCORALIS IN COMPLEX WITH ITS PHYSIOLOGICAL LIGAND DAFACHRONIC ACID DELTA 4  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, DAFACHRONIC ACID, SRC1, NEMATODE, STRONGYLOIDES STERCORALIS, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1err:B   (GLY420) to   (HIS550)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, ANTAGONIST 
1fcz:A   (THR308) to   (GLU417)  ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156  |   ISOTYPE SELECTIVITY, RETINOID LIGAND COMPLEXES, DRUG DESIGN, ANTIPARALLEL ALPHA-HELICAL SANDWICH FOLD, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION 
1fm6:D   (LYS358) to   (TYR473)  THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION 
1fm6:X   (GLU365) to   (TYR473)  THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION 
2vix:A   (MET250) to   (TYR349)  METHYLATED SHIGELLA FLEXNERI MXIC  |   TRANSPORT PROTEIN, SECRETION REGULATION, T3SS, VIRULENCE, TYPE THREE SECRETION SYSTEM 
2vix:B   (MET250) to   (TYR349)  METHYLATED SHIGELLA FLEXNERI MXIC  |   TRANSPORT PROTEIN, SECRETION REGULATION, T3SS, VIRULENCE, TYPE THREE SECRETION SYSTEM 
1sj0:A   (MET421) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE ANTAGONIST LIGAND 4-D  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2vv0:B   (LYS358) to   (TYR473)  HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA  |   NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, DIABETES MELLITUS, ZINC-FINGER, DNA-BINDING, POLYMORPHISM, TRANSCRIPTION, ZINC, OBESITY, NUCLEUS, RECEPTOR, ACTIVATOR, OXIDISED FATTY ACID, TRANSCRIPTION FACTOR, METAL-BINDING, PHOSPHOPROTEIN, DISEASE MUTATION 
3vdx:C   (LEU279) to   (ASN368)  STRUCTURE OF A 16 NM PROTEIN CAGE DESIGNED BY FUSING SYMMETRIC OLIGOMERIC DOMAINS  |   PROTEIN DESIGN, BIONANOTECHNOLOGY, PROTEIN ASSEMBLY, SYMMETRY, BIOMATERIALS, DE NOVO PROTEIN 
3vjh:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH JKPL35  |   TRANSCRIPTION 
3vjt:A   (THR302) to   (LEU410)  VITAMIN D RECEPTOR COMPLEX WITH A CARBORANE COMPOUND  |   NUCLEAR RECEPTOR, SYNTHETIC AGONIST, CARBORANE, TRANSCRIPTION 
4zn7:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH DIETHYLSTILBESTROL  |   NUCLEAR RECEPTOR TRANSCRIPTION FACTOR NUCLEUS PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
4zn7:B   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH DIETHYLSTILBESTROL  |   NUCLEAR RECEPTOR TRANSCRIPTION FACTOR NUCLEUS PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
4znu:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHYL-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4l96:A   (PRO359) to   (ASP475)  STRUCTURE OF THE COMPLEX BETWEEN THE F360L PPARGAMMA MUTANT AND THE LIGAND LT175 (SPACE GROUP I222)  |   TRANSCRIPTION FACTOR, RXRALPHA, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX 
3ipq:A   (VAL333) to   (TRP443)  X-RAY STRUCTURE OF GW3965 SYNTHETIC AGONIST BOUND TO THE LXR-ALPHA  |   NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, DNA-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, ACYLTRANSFERASE, CHROMOSOMAL REARRANGEMENT, ISOPEPTIDE BOND, PHOSPHOPROTEIN, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION 
2hb8:A   (SER306) to   (PHE422)  CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-METHYL CALCITRIOL  |   ALPHA HELICAL SANDWICH, GENE REGULATION 
2hbh:A   (THR334) to   (LEU440)  CRYSTAL STRUCTURE OF VITAMIN D NUCLEAR RECEPTOR LIGAND BINDING DOMAIN BOUND TO A LOCKED SIDE-CHAIN ANALOG OF CALCITRIOL AND SRC-1 PEPTIDE  |   ALPHA HELICAL SANDWICH, GENE REGULATION 
4ltr:C   (ILE150) to   (SER285)  BACTERIAL SODIUM CHANNEL, HIS245GLY MUTANT, I222 SPACE GROUP  |   CATION CHANNEL FOLD, COILED COIL SODIUM CHANNEL, PLASMA MEMBRANE, TRANSPORT PROTEIN 
1ie9:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D LIGAND BINDING DOMAIN BOUND TO MC1288  |   VDR, MC1288, GENE REGULATION 
1ulh:A   (ALA318) to   (THR415)  A SHORT PEPTIDE INSERTION CRUCIAL FOR ANGIOSTATIC ACTIVITY OF HUMAN TRYPTOPHANYL-TRNA SYNTHETASE  |   AMINOACYLATION, ANGIOSTATIC CYTOKINE, APOPTOSIS, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, STRUCTURAL GENOMICS, LIGASE 
5aav:A   (MET421) to   (HIS550)  OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-(3,5- DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2, 3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT AND ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR AND ANTAGONIST  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, AZD9496, NUCLEAR HORMONE RECEPTOR 
5aav:B   (VAL422) to   (ASP545)  OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-(3,5- DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2, 3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT AND ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR AND ANTAGONIST  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, AZD9496, NUCLEAR HORMONE RECEPTOR 
5acc:A   (MET421) to   (LEU544)  A NOVEL ORAL SELECTIVE ESTROGEN RECEPTOR DOWN-REGULATOR, AZD9496, DRIVES TUMOUR GROWTH INHIBITION IN ESTROGEN RECEPTOR POSITIVE AND ESR1 MUTANT MODELS  |   SIGNALING PROTEIN, SERD, METASTATIC BREAST CANCER, ER MUTATION, ESR1 MUTATION, COMBINATION THERAPY 
3wgp:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   STEROID HORMON RECEPTOR FAMILY MEMBER, HORMONE RECEPTOR 
5ak2:A   (GLU423) to   (HIS550)  OXYPHENYLPROPENOIC ACIDS AS ORAL SELECTIVE ESTROGEN RECEPTOR DOWN-REGULATORS.  |   SIGNALING PROTEIN 
3wmh:A   (LYS358) to   (LYS474)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMMA SELECTIVE SYNTHETIC PARTIAL AGONIST MEKT75  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
3wmh:B   (LYS358) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A GAMMMA SELECTIVE SYNTHETIC PARTIAL AGONIST MEKT75  |   MAINLY ALPHA, NUCLEAR RECEPTOR, TRANSCRIPTION 
2lbd:A   (THR308) to   (GLU417)  LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID  |   NUCLEAR RECEPTOR, RETINOIC ACID RECEPTOR, ALL-TRANS RETINOIC ACID, LIGAND-BINDING DOMAIN, COMPLEX, HOLO FORM, TRANSCRIPTION REGULATION, LIGAND-DEPENDENT, ACTIVE CONFORMATION, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
2yfe:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN 1  |   RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE 
1x76:A   (ILE373) to   (ALA497)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST 
2ylo:A   (TYR781) to   (GLN902)  TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH IN SILICO MOLECULAR MODELING  |   HORMONE RECEPTOR, BINDING FUNCTION 3 
2yly:A   (GLU371) to   (ALA497)  SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS.  |   RECEPTOR 
2o4r:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH VITIII 17-20E AND THE NR2 BOX OF DRIP 205  |   NUCLEAR RECEPTOR-LIGAND COMPLEX, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
4a4w:A   (ARG357) to   (TYR473)  LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN 2  |   RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE 
1xp9:A   (MET421) to   (MET543)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2zmj:A   (THR302) to   (LEU410)  CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO ADAMANTYL VITAMIN D ANALOGS: STRUCTURAL BASIS FOR VITAMIN D RECEPTOR ANTAGONISM AND/OR PARTIAL AGONISM  |   NUCLEAR RECEPTOR-ANTAGONIST COMPLEX, DNA-BINDING, METAL- BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR 
2znq:A   (LYS358) to   (TYR473)  HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP401  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
2znq:B   (LYS358) to   (TYR473)  HUMAN PPAR DELTA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST TIPP401  |   NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, ACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
1yye:A   (ILE373) to   (LEU500)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-202196  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST 
4ppp:A   (GLN441) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH FLUORO-RESVERATROL  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, PROTEIN BINDING 
4ppp:B   (GLN441) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH FLUORO-RESVERATROL  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, PROTEIN BINDING 
4pps:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN A-CD RING ESTROGEN DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, PROTEIN BINDING 
4pvu:A   (PRO359) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA-LBD AND THE R ENANTIOMER OF MBX-102 (METAGLIDASEN)  |   ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, ACTIVATOR, TDNA- BINDING, NUCLEUS, OBESITY, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION 
4pvu:B   (PRO359) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA-LBD AND THE R ENANTIOMER OF MBX-102 (METAGLIDASEN)  |   ALPHA-HELICES, SMALL FOUR-STRANDED BETA-SHEET, ACTIVATOR, TDNA- BINDING, NUCLEUS, OBESITY, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION 
5dvs:A   (MET421) to   (ALA546)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-METHYL-SUBSTITUTED TRIARYL-IMINE 4,4'-[(2-METHYLPHENYL) CARBONIMIDOYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dvs:B   (VAL422) to   (ALA546)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-METHYL-SUBSTITUTED TRIARYL-IMINE 4,4'-[(2-METHYLPHENYL) CARBONIMIDOYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dx3:A   (MET421) to   (ASP545)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P3 AND ESTRADIOL  |   SYNTHETIC PEPTIDE, STAPLED PEPTIDE, ESTROGEN RECEPTOR ALPHA, SOMATIC MUTATION, PEPTIDE MIMETIC, AF-2 BINDING, HORMONE RECEPTOR-PEPTIDE COMPLEX 
5dyb:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-(3,4-DIHYDRONAPHTHALEN-2(1H)- YLIDENEMETHANEDIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dyb:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-(3,4-DIHYDRONAPHTHALEN-2(1H)- YLIDENEMETHANEDIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e0x:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(4-METHOXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e0x:B   (VAL422) to   (VAL533)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(4-METHOXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
3aur:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH YNE-DIENE TYPE ANALOG OF ACTIVE 14-EPI-2BETA- METHYL-19-NORVITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
3ax8:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE OF THE HUMAN VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 15ALPHA-METHOXY-1ALPHA,25-DIHYDROXYVITAMIN D3  |   HORMONE RECEPTOR, TRANSCRIPTION 
3az2:A   (SER306) to   (GLY423)  CRYSTAL STRUCTURE ANALYSIS OF VITAMIN D RECEPTOR  |   VITAMIN D RECEPTOR, HORMONE RECEPTOR 
3b0r:A   (ARG357) to   (TYR473)  HUMAN PPAR GAMMA LIGAND BINDING DMAIN COMPLEXED WITH GW9662 IN A COVALENT BONDED FORM  |   NUCLEAR RECEPTOR, TRANSCRIPTION 
3b5r:A   (TYR781) to   (SER888)  CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH SARM C-31  |   ANDROGEN RECEPTOR, NONSTEROIDAL, SARM, DISEASE MUTATION, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, POLYMORPHISM, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, TRIPLET REPEAT EXPANSION, UBL CONJUGATION, ZINC, ZINC-FINGER 
4rbn:D   (ILE189) to   (ILE261)  THE CRYSTAL STRUCTURE OF NITROSOMONAS EUROPAEA SUCROSE SYNTHASE: INSIGHTS INTO THE EVOLUTIONARY ORIGIN OF SUCROSE METABOLISM IN PROKARYOTES  |   SUCROSE SYNTHASE, ROSSMANN FOLD, GLUCOSYLTRANSFERASE, NDP-GLUCOSE, D- FRUCTOSE, NDP, SUCROSE, CYTOSOL, TRANSFERASE 
5fqv:A   (MET421) to   (LEU544)  SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR ANTAGONISTS: TETRAHYDROISOQUINOLINE PHENOLS 5.  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, THIQ, NUCLEAR HORMONE RECEPTOR 
3nsp:A   (GLY341) to   (GLY443)  CRYSTAL STRUCTURE OF TETRAMERIC RXRALPHA-LBD  |   NUCLEAR RECEPTOR RETINOIC X RECEPOR ALPHA LIGAND BINDING DOMAIN, TRANSCRIPTION 
3cs6:A   (SER306) to   (PHE422)  STRUCTURE-BASED DESIGN OF A SUPERAGONIST LIGAND FOR THE VITAMIN D NUCLEAR RECEPTOR  |   VDR, AGONIST, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, GENE REGULATION 
3d6d:A   (ARG357) to   (TYR473)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN PPARGAMMA LBD AND THE LT175(R-ENANTIOMER)  |   BUNDLE OF ALPHA-HELICES AND A SMALL FOUR-STRANDED BETA- SHEET, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
3peq:A   (LYS358) to   (TYR473)  PPARD COMPLEXED WITH A PHENOXYACETIC ACID PARTIAL AGONIST  |   PPAR NUCLEAR RECEPTOR, TRANSCRIPTION-TRANSCRIPTION AGONIST COMPLEX 
3peq:B   (LYS358) to   (MET476)  PPARD COMPLEXED WITH A PHENOXYACETIC ACID PARTIAL AGONIST  |   PPAR NUCLEAR RECEPTOR, TRANSCRIPTION-TRANSCRIPTION AGONIST COMPLEX 
4ema:A   (ARG357) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH ROSIGLITAZONE  |   NUCLEAR RECEPTOR, RETINOIC ACID RECEPTOR, NUCLEUS, TRANSCRIPTION 
4ema:B   (LYS358) to   (TYR473)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA IN COMPLEX WITH ROSIGLITAZONE  |   NUCLEAR RECEPTOR, RETINOIC ACID RECEPTOR, NUCLEUS, TRANSCRIPTION 
4g2h:A   (THR334) to   (LEU440)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   VDR, TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, TRASNCRIPTION REGULATION, LIGAND, DNA, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX 
5kcd:A   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL SUBSTITUTED OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kcd:B   (MET421) to   (ARG548)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL SUBSTITUTED OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION